<?xml version="1.0" encoding="iso-8859-1"?> 
<rss version="2.0" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" 
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" 
xmlns:atom="http://www.w3.org/2005/Atom"
>
<channel>
<title>International Journal of Medical Sciences</title> 
<link>http://www.medsci.org</link> 
<description>International Journal of Medical Sciences RSS feed -- Volume 8</description> 
<language>en-us</language> 
<pubDate>Tue, 20 Nov 2012 04:00:00 GMT</pubDate>
<lastBuildDate>Tue, 20 Nov 2012 04:00:00 GMT</lastBuildDate> 

<item>
<link>http://www.medsci.org/v08p0717.htm</link> 
<title>A Paired-Comparision of the MultiFunction CardioGramsm (MCG) and Sestamibi SPECT Myocardial Perfusion Imaging (MPI) to Quantitative Coronary Angiography for the Detection of Relevant Coronary Artery Obstruction (&#8805;70%) - A Single-Center Study of 116 Consecutive Patients Referred for Coronary Angiography</title> 
<description><![CDATA[ <p><b>Background:</b> An analysis of the US National Cardiovascular Data Registry has revealed that only 38% of patients referred for coronary angiography after non-invasive coronary testing have relevant coronary obstruction (CO) (&#8805;70%) of one or more coronary arteries.</p><p><b>Methods:</b> A single-center trial was undertaken in 165 consecutive, symptomatic patients with either known or suspected coronary disease and/or valve disease(VHD) who agreed to undergo cardiac catheterization and coronary angiography if stress myocardial perfusion imaging was abnormal. A total of 116 patients with abnormal SPECT MPI tests, persistent chest pain, or significant VHD underwent final analysis. An MCG coronary obstruction (CO) score of &#8805; 4.0 was considered indicative of relevant CO (&#8805;70%) in one or more coronary arteries. Angiographic results were finalized by consensus of two angiographers.</p><p><b>Results:</b> CO (&#8805;70%) was present in 53 of 116 patients (46%). The MCG CO score was significantly higher for patients with relevant CO (5.4 &#177; 1.9 vs. 2.5 &#177; 1.9). The MCG correctly classified 103 of the 116 patients (89%) enrolled in the study as either having or not having CO (&#8805;70%) (sensitivity- 91%; specificity- 87%; NPV- 92%; PPV- 86%). SPECT MPI was abnormal in 99 of the 116 (85%) patients undergoing catheterization, but correctly classified only 54 of the 116 patients (47%) entered in the study as either having or not having relevant CO (sensitivity-85%; specificity-14%; NPV - 53%; PPV- 45%).</p><p><b>Conclusions:</b> The MCG was shown in this paired-comparison trial with SPECT MPI to safely and accurately identify patients with relevant CO (&#8805;70%) prior to catheterization.</p> ]]></description>  
<dc:creator>John E. Strobeck, Anthony Mangieri, Norbert Rainford</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>717</prism:startingPage> 
<prism:endingPage>724</prism:endingPage> 
<pubDate>2011-10-28</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0711.htm</link> 
<title>Lateral Ventricular Meningioma Presenting with Intraventricular Hemorrhage: A Case Report and Literature Review</title> 
<description><![CDATA[ <p>Lateral ventricular meningiomas presenting with primary intraventricular hemorrhage are extremely uncommon. We report here a case of primary intraventricular hemorrhage attributable to a lateral ventricular meningioma. This case concerns a 46-year-old female patient who presented with sudden onset of headache. Computed tomography (CT), computed tomography angiography (CTA) and magnetic resonance imaging (MRI) examinations showed hemorrhage from a ruptured tumor mass, which was pathologically confirmed as a transitional meningioma. The patient underwent surgical treatment and had a good prognosis. A retrospective review of eight previous cases of hemorrhage from ruptured lateral ventricular meningiomas revealed that hemorrhage of lateral ventricular meningiomas and hemorrhage of meningiomas at other intracranial sites have similar causes. The clinical and pathological features of ruptured lateral ventricular meningiomas are consistent with those of unruptured lateral ventricular meningiomas. As this clinical entity is extremely rare, attention is called for while performing differential diagnosis.</p> ]]></description>  
<dc:creator>Zhenyu Fu, Kan Xu, Bing Xu, Limei Qu, Jinlu Yu</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>711</prism:startingPage> 
<prism:endingPage>716</prism:endingPage> 
<pubDate>2011-10-26</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0709.htm</link> 
<title>Large Mass Arising From the Tongue as an Initially and Sole Manifestation of Kaposi Sarcoma</title> 
<description><![CDATA[ <p>We report a 30- year-old Iranian woman presenting with a red to yellowish, well demarcated, painless exophytic and lobulated mass originating from the right hand side of the tongue. An excisional biopsy was obtained and it was diagnosed histopathologically as Kaposi's sarcoma by detecting atypical spindle cells with rare mitoses delineating blood-filled vascular slits.</p> ]]></description>  
<dc:creator>Amir Feily, Esmaeil Rafeie, Zahra Moosavi, Ahmad Khazanee, Nastaran Ranjbari, Kambiz Masoumi, Omid Ghasemzadeh, Mosleh Safarpoor</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>709</prism:startingPage> 
<prism:endingPage>710</prism:endingPage> 
<pubDate>2011-10-26</pubDate>
<category>Letter To The Editor</category>
</item>

<item>
<link>http://www.medsci.org/v08p0704.htm</link> 
<title>The Effect of Irrigation Temperature on Bone Healing</title> 
<description><![CDATA[ <p>Objective: Osteotomies, performed by rotational instruments, can cause temperature rise on the bone and elevated temperature can disrupt the bone healing. When the osteotomies are performed for the insertion of miniscrews, the bone healing disruption may cause stability loosening or failures. Saline irrigation is mostly used for the prevention of the heat generation during osteotomy.</p><p>Purpose: The purpose of this study was to evaluate the effect of the saline irrigation temperature on bone healing.</p><p>Material and Method: Standardized drilling and miniscrew placement was performed in the tibias of 18 Sprague Dawley rats with rotating bur uncooled, cooled with 25&#176;C and 4&#176;C saline irrigations. After the 21 days, the difference in healing was observed between the uncooled and cooled groups.</p><p>Results: Although there was no statistically significant difference between the group irrigated with 25&#176;C and 4&#176;C saline for newly bone formation, osteoblasts were seen more active and bone marrow was more dynamic in group 4&#176;C than group 25&#176;C. There is no disadvantage to use 25&#176;C, but it may be better to use 4&#176;C for rapid healing.</p> ]]></description>  
<dc:creator>Sabri Cemil Isler, Erol Cansiz, Cem Tanyel, Merva Soluk, Firat Selvi, Zerrin Cebi</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>704</prism:startingPage> 
<prism:endingPage>708</prism:endingPage> 
<pubDate>2011-10-22</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0679.htm</link> 
<title>Anorexia Nervosa: A Unified Neurological Perspective</title> 
<description><![CDATA[ <p>The roles of corticotrophin-releasing factor (CRF), opioid peptides, leptin and ghrelin in anorexia nervosa (AN) were discussed in this paper. CRF is the key mediator of the hypothalamo-pituitary-adrenal (HPA) axis and also acts at various other parts of the brain, such as the limbic system and the peripheral nervous system. CRF action is mediated through the CRF1 and CRF2 receptors, with both HPA axis-dependent and HPA axis-independent actions, where the latter shows nil involvement of the autonomic nervous system. CRF1 receptors mediate both the HPA axis-dependent and independent pathways through CRF, while the CRF2 receptors exclusively mediate the HPA axis-independent pathways through urocortin. Opioid peptides are involved in the adaptation and regulation of energy intake and utilization through reward-related behavior. Opioids play a role in the addictive component of AN, as described by the &#8220;auto-addiction opioids theory&#8221;. Their interactions have demonstrated the psychological aspect of AN and have shown to prevent the functioning of the physiological homeostasis. Important opioids involved are &#946;-lipotropin, &#946;-endorphin and dynorphin, which interact with both &#181; and &#954; opioids receptors to regulate reward-mediated behavior and describe the higher incidence of AN seen in females. Moreover, ghrelin is known as the &#8220;hunger&#8221; hormone and helps stimulate growth hormone (GH) and hepatic insulin-like-growth-factor-1(IGF-1), maintaining anabolism and preserving a lean body mass. In AN, high levels of GH due to GH resistance along with low levels of IGF-1 are observed. Leptin plays a role in suppressing appetite through the inhibition of neuropeptide Y gene. Moreover, the CRF, opioid, leptin and ghrelin mechanisms operate collectively at the HPA axis and express the physiological and psychological components of AN. Fear conditioning is an intricate learning process occurring at the level of the hippocampus, amygdala, lateral septum and the dorsal raphe by involving three distinct pathways, the HPA axis-independent pathway, hypercortisolemia and ghrelin. Opioids mediate CRF through noradrenergic stimulation in association with the locus coeruleus. Furthermore, CRF's inhibitory effect on gonadotropin releasing hormone can be further explained by the direct relationship seen between CRF and opioids. Low levels of gonadotropin have been demonstrated in AN where only estrogen has shown to mediate energy intake. In addition, estrogen is involved in regulating &#181; receptor concentrations, but in turn both CRF and opioids regulate estrogen. Moreover, opioids and leptin are both an effect of AN, while many studies have demonstrated a causal relationship between CRF and anorexic behavior. Moreover, leptin, estrogen and ghrelin play a role as predictors of survival in starvation. Since both leptin and estrogen are associated with higher levels of bone marrow fat they represent a longer survival than those who favor the ghrelin pathway. Future studies should consider cohort studies involving prepubertal males and females with high CRF. This would help prevent the extrapolation of results from studies on mice and draw more meaningful conclusions in humans. Studies should also consider these mechanisms in post-AN patients, as well as look into what predisposes certain individuals to develop AN. Finally, due to its complex pathogenesis the treatment of AN should focus on both the pharmacological and behavioral perspectives.</p> ]]></description>  
<dc:creator>Tasneem Fatema Hasan, Hunaid Hasan</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>679</prism:startingPage> 
<prism:endingPage>703</prism:endingPage> 
<pubDate>2011-10-22</pubDate>
<category>Review</category>
</item>

<item>
<link>http://www.medsci.org/v08p0673.htm</link> 
<title>Comparison of Cervical Parameters by Three-Dimensional Ultrasound according to Parity and Previous Delivery Mode</title> 
<description><![CDATA[ <p><b>Background:</b> We would like to find out that whether the patient's parity, previous delivery mode and previous labor could influence cervical parameters. Cervical length, volume and width were measured using two-dimensional (2D) and three-dimensional (3D) transvaginal ultrasound on normal pregnant women.</p><p><b>Method:</b> This study was conducted between January 2009 and December 2010 in singleton pregnant women who were admitted for routine antenatal care at hospitals in affiliation with the Catholic University, Seoul, Korea. The study group was classified by parity (nullipara and multipara) and previous delivery mode (cesarean section group and vaginal delivery group). The previous cesarean section group was divided by elective group who did not undergo labor and labor group who underwent labor. Cervical parameters such as cervical length, volume and width were measured using 2D and 3D ultrasound examinations in the first and second trimesters and the results were analyzed between those groups mentioned above.</p><p><b>Results:</b> One hundred and twenty-one pregnant women in their 1st trimester and 233 pregnant women in their 2nd trimester (a total of 354) were enrolled in this study. Cervical parameters were not statistically significant from parity, nor previous delivery mode and previous labor in 1st trimester. Cervical volumes were not statistically significant from nullipara and elective cesarean section groups (35.96&#177;9.81 vs. 34.73&#177;9.75 cm3), but the nullipara groups were significantly lowered in the vaginal group (35.96&#177;9.81 vs. 43.10&#177;11.87 cm3) in 2nd trimester. For the nullipara group, cervical widths were not statistically significant in the elective cesarean section group but these were significantly lower than labor and previous vaginal group in the 2nd trimester.</p><p><b>Conclusion:</b> The cervical volume and width have an influence on parity, previous delivery mode and labor in the 2nd trimester.</p> ]]></description>  
<dc:creator>Yun Sung Jo, Dong Gyu Jang, Narinay Kim, Sa Jin Kim, Guisera Lee</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>673</prism:startingPage> 
<prism:endingPage>678</prism:endingPage> 
<pubDate>2011-10-21</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0667.htm</link> 
<title>Use of Cone-Beam Computerized Tomography for Evaluation of Bisphosphonate-Associated Osteonecrosis of the Jaws in an Experimental Rat Model</title> 
<description><![CDATA[ <p><b>Background:</b> Bisphosphonate-induced osteonecrosis of the jaw (BONJ) is a frequently reported complication. The aim of this study was to investigate the clinical and histopathological presentation of BONJ with the Hounsfield score and to evaluate the reliability of the score for determining necrosis in an animal model.</p><p><b>Material/Methods:</b> Eighty rats were prospectively and randomly divided into two groups of 40 each: a control group and an experimental group. Half of the animals from each group underwent extraction of the left mandibular molars, and the other half underwent extraction of the left maxillary molars under pentobarbital-induced general anesthesia. All animals were euthanized 28 days after tooth extraction. Maxillae and mandibles were extracted, cone beam computed tomography (CBCT) was performed, and Hounsfield scores were evaluated.</p><p><b>Results:</b> The Hounsfield scores of the experimental group were found to be compatible with chronic osteomyelitis and periosteal reactions. The Hounsfield scores of the control group were compatible with a healthy healing period.</p><p><b>Conclusion:</b> In light of these results, both cone beam computed tomography (CBCT) and the Hounsfield Units (HU) evaluations together are thought to be efficient in the diagnosis of BONJ.</p> ]]></description>  
<dc:creator>Abdulkadir Burak Cankaya, Mehmet Ali Erdem, Sabri Cemil Isler, Sabit Demircan, Merva Soluk, Cetin Kasapoglu, Cuneyt Korhan Oral</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>667</prism:startingPage> 
<prism:endingPage>672</prism:endingPage> 
<pubDate>2011-10-21</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0659.htm</link> 
<title>Repercussions of Surgically Assisted Maxillary Expansion on Nose Width and Position of Septum and Inferior Nasal Conchae</title> 
<description><![CDATA[ <p>The aim of the present study was to assess the clinical and radiographic repercussions of surgically assisted maxillary expansion on the septum, nasal cavity and nasal conchae. The sample was made up of 15 patients with skeletal maturity (9 females and 6 males between 16 and 45 years of age) and maxillary transverse deficiency. Assessments were performed through anterior rhinoscopy and frontal cephalometric radiographs on three occasions: (T0) preoperative period, (T1) locking of the expander and (T2) six months following the locking procedure. An increase was observed in the basal portion of the pyriform aperture and distances between the lateral wall of the basal portion of the pyriform aperture and the septum. The radiographic exam revealed that the nasal septum did not undergo any statistically significant change in its position. Moreover, no significant changes in the position of the nasal septum or nasal conchae were detected throughout the three evaluation times. The results suggest that surgically assisted maxillary expansion is capable of widening the basal portion of the pyriform aperture, with little repercussion on the anterior position of the nasal septum and inferior nasal conchae.</p> ]]></description>  
<dc:creator>Fabr&#237;cio Souza Landim, George Borba Freitas, Andreana Braga Malouf, Liana P. Carvalho Studart, Nelson Studart Rocha, Emanuel S&#225;vio de Souza Andrade, Ant&#244;nio Figueiredo Caubi, Jos&#233; Rodrigues Laureano Filho, Emanuel Dias Oliveira e Silva</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>659</prism:startingPage> 
<prism:endingPage>666</prism:endingPage> 
<pubDate>2011-10-21</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0653.htm</link> 
<title>Body Weight Reducing Effect of Oral Boric Acid Intake</title> 
<description><![CDATA[ <p><b>Background: </b>Boric acid is widely used in biology, but its body weight reducing effect is not researched.</p><p><b>Methods: </b>Twenty mice were divided into two equal groups. Control group mice drank standard tap water, but study group mice drank 0.28mg/250ml boric acid added tap water over five days. Total body weight changes, major organ histopathology, blood biochemistry, urine and feces analyses were compared.</p><p><b>Results: </b>Study group mice lost body weight mean 28.1% but in control group no weight loss and also weight gained mean 0.09% (p&#60;0.001). Total drinking water and urine outputs were not statistically different. Cholesterol, LDL, AST, ALT, LDH, amylase and urobilinogen levels were statistically significantly high in the study group. Other variables were not statistically different. No histopathologic differences were detected in evaluations of all resected major organs.</p><p><b>Conclusion: </b>Low dose oral boric acid intake cause serious body weight reduction. Blood and urine analyses support high glucose, lipid and middle protein catabolisms, but the mechanism is unclear.</p> ]]></description>  
<dc:creator>Erhan Aysan, Fikrettin Sahin, Dilek Telci, Mehmet Emir Yalvac, Sinem Hocaoglu Emre, Cetin Karaca, Mahmut Muslumanoglu</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>653</prism:startingPage> 
<prism:endingPage>658</prism:endingPage> 
<pubDate>2011-10-21</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0649.htm</link> 
<title>Oral Piercing and Oral Diseases: A Short Time Retrospective Study</title> 
<description><![CDATA[ <p>Body piercing indicates the puncturing of a part of the body in which jewelry may be worn. In recent years, oral piercing is increasingly popular especially among young people. Body piercing has to be considered as a surgical procedure to all intents and purposes and, as such, has to be performed only by qualified personnel able to assure high standards of professionalism in facilities subject to sanitary inspections.</p><p>The aim of the present work is to verify what risks patients may be exposed to and what complications may occur after a healthcare professional performs oral piercing.</p><p>Our retrospective study includes 108 patients (74 males and 34 females) aged between 14 and 39 years, who had oral piercing done 12&#177;4 months earlier. All the patients underwent clinical examination to reveal the possible presence of late complications. After piercing, none of the 108 patients developed widespread complications.</p><p>Although all patients said they had followed the piercers' instructions, 96% of them reported postoperative local complications such as bleeding within 12 hours of piercing (90%), perilesional edema for 3&#177;2 days after piercing surgery (80%), and persistent mucosal atrophy (70%).</p> ]]></description>  
<dc:creator>Francesco Inchingolo, Marco Tatullo, Fabio M. Abenavoli, Massimo Marrelli, Alessio D. Inchingolo, Antonio Palladino, Angelo M. Inchingolo, Gianna Dipalma</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>649</prism:startingPage> 
<prism:endingPage>652</prism:endingPage> 
<pubDate>2011-10-18</pubDate>
<category>Short Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0643.htm</link> 
<title>Umbilical Arterial Blood Gas and Perinatal Outcome in the Second Twin according to the Planned Mode of Delivery</title> 
<description><![CDATA[ <p><b>Purpose:</b> To compare umbilical arterial gas parameters in the second twin of twin pregnancies according to the mode of delivery</p><p><b>Methods:</b> We retrospectively analyzed the medical records of twin deliveries after 34 weeks of gestation for 3 years. Excluding the cases which underwent emergency cesarean delivery during trial of labor, a total of 79 twin gestations had umbilical arterial blood gas values available and were and divided into cesarean delivery group (N=40) and vaginal delivery group (N=39). The mean differences of umbilical arterial blood parameters and the Apgar score between the first and second twin in each pregnancy were compared according the mode of delivery.</p><p><b>Results:</b> The differences of umbilical arterial gas parameters between twin siblings showed no significant difference according to the mode of delivery. With regard to the 1 minute and 5 minute Apgar scores, the differences between twin siblings are significantly increased in vaginal delivery group compared to cesarean delivery group (p=0.048, and p=0.038, respectively). In comparing the 28 cases delivered vaginally with an inter-twin delivery interval &#60; 10 minutes and 40 cases delivered by cesarean section, no significant differences were observed in the umbilical arterial gas parameters and Apgar scores.</p><p><b>Conclusion:</b> The inter-twin umbilical arterial blood gas parameters according to the mode of delivery showed no difference. For twin deliveries, it is relatively safe to plan for a vaginal delivery, but an effort should be made to reduce the inter-twin delivery interval time.</p> ]]></description>  
<dc:creator>Ji Young Kwon, Won Sik Yoon, Gui Se Ra Lee, Sa Jin Kim, Jong Chul Shin, In Yang Park</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>643</prism:startingPage> 
<prism:endingPage>648</prism:endingPage> 
<pubDate>2011-10-15</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0640.htm</link> 
<title>Subarachnoid Hemorrhage Associated with Epidemic Hemorrhagic Fever: A Rare Case Report</title> 
<description><![CDATA[ <p>Nervous system injuries associated with epidemic hemorrhagic fever (EHF) are not rarely seen. However, cerebrovascular disease arising from EHF is rarely reported in the literature. A 50-year-old male patient suffered from subarachnoid hemorrhage (SAH). No abnormal condition was found in intracranial vascular digital subtraction angiography (DSA). But, this patient presented with positive hantavirus-IgM and IgG, with typical clinical process, which lead to the diagnosis of EHF followed by SAH. To our knowledge, SAH associated with EHF has not been previously reported. A meticulous assessment of EHF patients with a serious condition had one or more central nervous system (CNS) abnormalities, such as sudden headache, vomiting, confusion, meningismus, and convulsions, which is necessary for diagnosing and giving timely treatment to improve the prognosis.</p> ]]></description>  
<dc:creator>Zucai Xu, Ping Xu, Xianze Lei, Zhongxiang Xu, Qisi Wu, Jun Zhang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>8</prism:number> 
<prism:startingPage>640</prism:startingPage> 
<prism:endingPage>642</prism:endingPage> 
<pubDate>2011-10-15</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0635.htm</link> 
<title>Multiple Aspergillus Cerebellar Abscesses in a Middle-Aged Female: Case Report and Literature Review</title> 
<description><![CDATA[ <p><i>Aspergillus</i> abscesses in the cerebellum are extremely rare, and most cases are solitary. Here, we report the first case of multiple <i>Aspergillus</i> cerebellar abscesses in a 46-year-old female after one mastoidectomy, two craniectomies, and extended use of antibiotics. The possible pathogenesis of this unusual event is discussed. Good outcome was achieved by treatment with a combination of neurosurgical resection and voriconazole (VRC) administration, which we suggest is a potential management plan.</p> ]]></description>  
<dc:creator>Sheng Chen, Jia-Li Pu, Jun Yu, Jian-Min Zhang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>635</prism:startingPage> 
<prism:endingPage>639</prism:endingPage> 
<pubDate>2011-10-14</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0628.htm</link> 
<title>Comparison of Nutritional Parameters among Adult and Elderly Hemodialysis Patients</title> 
<description><![CDATA[ <p><b>Aim:</b> The aim of this study was to compare the nutritional biochemical parameters, prealbumin levels, and bioimpedance analysis parameters of adult and elderly hemodialysis (HD) patients.</p><p><b>Methods: </b>This prospective cross-sectional study included 50 adult HD patients (42.0 % female). Nutritional status was assessed by post-dialysis multifrequency bioimpedance analysis (BIA), serum prealbumin and other nutritional biochemical parameters.</p><p><b>Results:</b> Mean age of patients was 57.4&#177;15.1 years (range: 30-83 years) and mean dialysis duration was 68.3 &#177; 54.5 months (range: 3-240 months). When the patients were divided into two groups according to age of patients (&#60;65 and &#8805;65), prealbumin (p=0.003), blood urea nitrogen (BUN) (p=0.000), serum creatinine (p=0.013), albumin (p=0.016), protein catabolic rate per normalized body weight (nPCR) (p=0.001), intracellular water (ICW)/total body weight (0.003) , body fat mass (p00.000), lean body mass (p=0.031), lean dry mass (p=0.001), illness marker (p=0.005), basal metabolism (p=0.007), body mass index (BMI) (p=0.028), body fat mass index (BFMI) (p=0.000), fat free mass index (FFMI) (p=0.040) values were significantly different between the groups. In the elderly patients (age &#8805;65), body fat mass, illness marker, BMI, BFMI were higher compared to adult patients (age &#60;65). Additionally, in the elderly patients, prealbumin, BUN, creatinine, albumin, nPCR, ICW/ total body weight, lean body weight, lean dry weight, basal metabolism and FFMI were lower than adult patients.</p><p><b>Conclusions:</b> Our results indicate that BFMI were higher, albumin, prealbumin, nPCR and lean body mass and FFMI were lower in elderly patients compared to adults. These results imply that elderly HD patients may be prone sarcopenic obesity and may require special nutritional support.</p> ]]></description>  
<dc:creator>G&#252;lperi &#199;elik, Bahar Oc, Inci Kara, M&#252;mtaz Y&#305;lmaz, Ali Yuceaktas, Seza Apiliogullari</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>628</prism:startingPage> 
<prism:endingPage>634</prism:endingPage> 
<pubDate>2011-10-13</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0623.htm</link> 
<title>Vapocoolant Spray vs Lidocaine/Prilocaine Cream for Reducing the Pain of Venipuncture in Hemodialysis Patients: A Randomized, Placebo-Controlled, Crossover Study</title> 
<description><![CDATA[ <p><b>Objective:</b> Patients undergoing hemodialysis are repeatedly exposed to stress and pain from approximately 300 punctures per year to their arteriovenous fistula. This study was designed to measure pain associated with venepuncture during AVF cannulation and to compare the effectiveness of ethyl chloride vapocoolant spray, topical eutectic mixture of local anesthetics (EMLA) cream and placebo in controlling pain caused by venepuncture of arteriovenous fistula patients undergoing chronic hemodialysis.</p><p><b>Methods:</b> This randomized, placebo-controlled, crossover study, included 41 patients undergoing conventional hemodialysis three times a week. First intervention was conducted as baseline pain assessment (control). In the three consecutive dialysis sessions, every patient randomly received 1) ethyl chloride vapocoolant spray, 2) EMLA, or 3) placebo cream before venepuncture. Pain perception was recorded by patients immediately after cannulation on a 0-100 mm visual analogue scale (VAS). p&#60;0.05 was considered as significant.</p><p><b>Results:</b> VAS scores presented a marked inter-individual variation during venepuncture. EMLA application resulted in significantly lower total pain scores compared to control and all other interventions (p&#60;0.05). No patient experienced severe pain with EMLA or vapocoolant. The patients reported less moderate and severe pain with EMLA, and vapocoolant spray compared to control and placebo interventions. Moderate and severe pain scores were similar between EMLA and vapocoolant spray (p&#62;0.05).</p><p><b>Conclusion:</b> Venipuncture for AVF cannulation causes mild to moderate pain in hemodialysis patients. Although local application of EMLA is more effective than in preventing venepuncture pain, ethyl chloride vapocoolant is as effective as EMLA for preventing mild to moderate puncture pain in patients undergoing hemodialysis.</p> ]]></description>  
<dc:creator>G&#252;lperi &#199;elik, Orhan &#214;zbek, M&#252;mtaz Y&#305;lmaz, Ipek Duman, Seda &#214;zbek, Seza Apiliogullari</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>623</prism:startingPage> 
<prism:endingPage>627</prism:endingPage> 
<pubDate>2011-10-12</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0615.htm</link> 
<title>A Double Blind, Randomized, Placebo Controlled Clinical Study Evaluates the Early Efficacy of Aflapin&#174; in Subjects with Osteoarthritis of Knee</title> 
<description><![CDATA[ <p>Aflapin<sup>&#174;</sup> is a novel synergistic composition derived from <i>Boswellia serrata </i>gum resin (Indian Patent Application No. 2229/CHE/2008). Aflapin is more efficacious as an anti-inflammatory agent compared to the existing <i>Boswellia</i> products, 5-Loxin<sup>&#174;</sup> and traditional 65% Boswellia extract. A 30-day, double-blind, randomized, placebo-controlled study was conducted to validate the efficacy of Aflapin<sup>&#174;</sup> in the management of clinical symptoms of osteoarthritis (OA) of the knee (Clinical trial registration number: ISRCTN69643551). Sixty eligible OA subjects selected through screening were included in the study. The subjects received either 100 mg (n=30) of Aflapin<sup>&#174;</sup> or placebo (n=30) daily for 30 days. Each subject was evaluated for pain and physical functions by using the standard tools (visual analog scale, Lequesne's Functional Index, and Western Ontario and McMaster Universities Osteoarthritis Index) at the baseline (day 0), and at days 5, 15 and 30. A series of biochemical tests in serum, urine and hematological parameters established the safety of Aflapin. The observations suggest that Aflapin conferred clinically and statistically significant improvements in pain scores and physical function scores in OA subjects. Aflapin provided significant improvements in pain score and functional ability in as early as 5 days of treatment. In conclusion, our observations suggest that Aflapin is a safe, fast acting and effective alternative intervention in the management of OA.</p> ]]></description>  
<dc:creator>Amar A. Vishal, Artatrana Mishra, Siba P Raychaudhuri</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>615</prism:startingPage> 
<prism:endingPage>622</prism:endingPage> 
<pubDate>2011-10-12</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0599.htm</link> 
<title>Overexpression of CD36 and Acyl-CoA Synthetases FATP2, FATP4 and ACSL1 Increases Fatty Acid Uptake in Human Hepatoma Cells</title> 
<description><![CDATA[ <p><b>Background:</b> Understanding the mechanisms of long chain fatty acid (LCFA) uptake in hepatic cells is of high medical importance to treat and to prevent fatty liver disease (FLD). ACSs (Acyl-CoA synthetases) are a family of enzymes that catalyze the esterification of fatty acids (FA) with CoA. Recent studies suggest that ACS enzymes drive the uptake of LCFA indirectly by their enzymatic activity and could promote special metabolic pathways dependent on their localization.</p><p>The only protein located at the plasma membrane which has consistently been shown to enhance FA uptake is CD36.</p><p><b>Aims: </b>The current study investigated whether ACSs and CD36 could regulate hepatic LCFA uptake.</p><p><b>Methods and Results:</b> FATP2 and FATP4 were both localized to the ER of HuH7 and HepG2 cells as shown by double immunofluorescence in comparison to marker proteins. ACSL1 was located at mitochondria in both cell lines. Overexpression of FATP2, FATP4 and ACSL1 highly increased ACS activity as well as the uptake of [3H]-oleic acid and fluorescent Bodipy-C12 (B12) fatty acid. Quantitative FACS analysis showed a correlation between ACS expression levels and B12 uptake. FATP2 had the highest effect on B12 uptake of all proteins tested. CD36 was mainly localized at the plasma membrane. Whereas [3H]-oleic acid uptake was increased after overexpression, CD36 had no effect on B12 uptake.</p><p><b>Conclusion</b>: Uptake of LCFA into hepatoma cells can be regulated by the expression levels of intracellular enzymes. We propose that ACS enzymes drive FA uptake indirectly by esterification. Therefore these molecules are potential targets for treatment of nonalcoholic fatty liver disease (NAFLD) or steatohepatitis (NASH).</p> ]]></description>  
<dc:creator>Julia Krammer, Margarete Digel, Friedrich Ehehalt, Wolfgang Stremmel, Joachim F&#252;llekrug, Robert Ehehalt</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>599</prism:startingPage> 
<prism:endingPage>614</prism:endingPage> 
<pubDate>2011-10-7</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0594.htm</link> 
<title>The Sonographic Umbilical Cord Coiling in Late Second Trimester of Gestation and Perinatal Outcomes</title> 
<description><![CDATA[ <p><b>Background:</b> This study was conducted to determine whether or not the umbilical cord coiling index (UCI) during the late second trimester of gestation is associated with perinatal outcomes.</p><p><b>Methods:</b> This was a retrospective study of 251 pregnancies in which a fetal anatomic survey with a recorded UCI was performed at 22-28 weeks gestation. The subjects were divided into normocoiled, hypocoiled, and hypercoiled groups and compared perinatal outcomes.</p><p><b>Results: </b>Two hundred twenty-six patients were included. The incidence of preterm deliveries in hypocoiled group was 35%, which was significantly greater than the normocoiled groups (p=0.041). The incidence of neonates with low birth weights in the hypocoiled group was 36.4%, which was significantly greater than the normocoiled groups (p=0.044). In the hypocoiled group, 27.3% of newborns were admitted to the NICU which was significantly greater than the normocoiled and hypercoiled groups (p=0.041). After the adjustment by logistic regression analysis, only preterm delivery were significantly increased in hypocoiled group (OR=9.6, 95% CI=2.09-44.07).</p><p><b>Conclusion: </b>The hyporcoiling of the umbilical cord during the late second trimester of pregnancy suggest that the risk for preterm delivery is high, consequently the delivery of low birthweight neonates is high, and the admission to the neonatal intensive care unit is increased.</p> ]]></description>  
<dc:creator>Yun Sung Jo, Dong Kue Jang, Guisera Lee</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>594</prism:startingPage> 
<prism:endingPage>598</prism:endingPage> 
<pubDate>2011-10-7</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0584.htm</link> 
<title>Evaluation of Light-Emitting Diode (LED-660 Nm) Application over Primary Osteoblast-Like Cells on Titanium Surfaces: An In Vitro Study</title> 
<description><![CDATA[ <p><b>Background:</b> The goal of this study was to evaluate the behavior of neonatal rat calvarial osteoblast-like cells cultured on different implant surfaces and exposed once or three times to a 660-nm light-emitting diode (LED).</p><p><b>Methods:</b> An LED with a 660-nm wavelength was applied once or three times to cultured cells on standard and modified sandblasted acid-etched surfaces (SLA and SLActive; Straumann, Basel, Switzerland). To analyze the effect of the LED on cell proliferation, numbers, and viability, cells were cultured on titanium discs, and measurements were taken after 72 h. Cell proliferation rates were assessed using a bromodeoxyuridine immunohistochemical technique. Cell morphologies were evaluated by scanning electron microscopy (SEM).</p><p><b>Results:</b> Osteoblast-like cells proliferated on all tested surfaces, with differences among groups in cell counts and DNA synthesis values. The application of one LED treatment caused a significant increase in cell count in the SLActive group in comparison with the SLA group (<i>p</i> = 0.001), whereas the application of three LED treatments caused a significant decrease in cell count in the SLA group compared with the SLActive group (<i>p</i> &#60; 0.001). After 72 h, the number of cells was highest in the SLActive group exposed once to the LED.</p><p><b>Conclusions:</b> One LED application in the SLActive group resulted in significantly increased cell numbers. However, these findings were not exactly compatible with the SEM findings, which demonstrated fewer cells and weak attachments between cells and to the surface. Thus, further studies using different LED application times are needed to clarify the reason for the increased number of cells that are apparently incapable of attaching to the titanium surfaces after 72 h.</p> ]]></description>  
<dc:creator>Abdulkadir Burak Cankaya, Mehmet Ali Erdem, Arzu P&#305;nar Erdem, Mine Erguven, Buket Aybar, Cetin Kasapoglu, Ayhan Bilir</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>584</prism:startingPage> 
<prism:endingPage>593</prism:endingPage> 
<pubDate>2011-10-4</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0577.htm</link> 
<title>Pregnancy Outcomes and Appropriate Timing of Pregnancy in 183 pregnancies in Korean Patients with SLE</title> 
<description><![CDATA[ <p>This study was undertaken to investigate the pregnancy outcomes in patients with systemic lupus erythematosus (SLE) and the appropriate timing of pregnancy. We performed a retrospective evaluation of 183 pregnancies with SLE at Catholic University Medical Center during the 13-year period from 1998 to 2010. Pregnancy outcomes were compared according to SLE characteristics. The predictive value of the different cut-off points of the stable period before conception on adverse pregnancy outcomes was calculated by ROC (Receiver operating characteristics) curve analysis. In multivariate analysis, the presence of antiphospholipid antibodies (aPLs) increased the risk of pregnancy loss (p&#60;0.0001) and premature birth (p=0.0040). Active disease at conception increased the risk of premature birth (p&#60; 0.0001) and complications (IUGR, PIH, or both) (p= 0.0078). The other predictor of complications was found to be lupus flare (p=0.0252). At a cut-off level of stable period of 4 months before conception, sensitivity and specificity were 70.8% and 53.2%, 71.4% and 61.5%, and 63.6 % and 59.8 %, respectively on reducing pregnancy loss, premature birth, and complications. Pregnancies with aPLs, active disease at conception and SLE flares are at a higher risk of adverse outcomes. It is essential that disease activity remains stable at least 4 months before conception, for favorable pregnancy outcomes.</p> ]]></description>  
<dc:creator>Hyun Sun Ko, Hyun Young Ahn, Dong Gyu Jang, Sae-Kyung Choi, Yong-Gyu Park, In Yang Park, Guisera Lee, Sung-Hwan Park, Jong Chul Shin</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>577</prism:startingPage> 
<prism:endingPage>583</prism:endingPage> 
<pubDate>2011-10-1</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0573.htm</link> 
<title>Monoamniotic Twins with One Fetal Anencephaly and Cord Entanglement Diagnosed with Three Dimensional Ultrasound at 14 Weeks of Gestation</title> 
<description><![CDATA[ <p>A 29-year-old pregnant woman with parity 0-0-0-0 was diagnosed with monoamniotic twin pregnancy discordant for anencephaly at 14 weeks gestation. Umbilical cord entanglement, which is an important cause of fetal death in monoamniotic twins, was confirmed by three-dimensional ultrasound. Cesarean section was performed at 34 weeks of gestation, and the normal newborn infant was discharged without any complications. We report a case of monoamniotic twin pregnancy discordant for anencephaly and diagnosed with cord entanglement by three-dimensional ultrasound at 14 weeks of gestation, and now report it along with a literature review.</p> ]]></description>  
<dc:creator>Yun Sung Jo, Hyun Joo Son, Dong Gyu Jang, Narinay Kim, Guisera Lee</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>573</prism:startingPage> 
<prism:endingPage>576</prism:endingPage> 
<pubDate>2011-9-29</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0564.htm</link> 
<title>Atorvastatin Inhibits Myocardial Cell Apoptosis in a Rat Model with Post-myocardial Infarction Heart Failure by Downregulating ER Stress Response</title> 
<description><![CDATA[ <p><b>Objective: </b>To determine the effect of atorvastatin on rat heart failure after myocardial infarction and to investigate the underlying mechanism of atorvastatin-mediated myocardium protection.</p><p><b>Methods:</b> Thirty-eight rats were randomly divided into three groups: a heart failure model group (model group), a heart failure plus atorvastatin treatment group (atorvastatin group) and a sham-surgery group (control group). The rat heart failure model was established by ligation of the left anterior descending of coronary arteries (LADs). Changes in hemodynamics parameters were recorded after the final drug administration. Plasma brain natriuretic peptide (BNP) concentration was determined by enzyme-linked immunosorbent assay (ELISA). Histological diagnosis was achieved by hematoxylin and eosin (H&#38;E) and Masson's trichrome staining. The expressions of 78kDa glucose-regulated protein 78 (GRP78), caspase-12 and C/EBP homologous protein (CHOP, also known as GADD153) in myocardial cells and cultured cardiac myocytes were examined by Western blot. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was used to evaluate myocardial cell apoptosis, and flow cytometry was performed to examine the cell apoptosis of cultured cardiac myocytes.</p><p><b>Results</b>: In the atorvastatin group, myocardial cells were lined up more orderly and myocardial fibrosis level was decreased compared to the model group. The expressions of GRP78, caspase-12 and CHOP in myocardial cells were decreased in atorvastatin group. Moreover, in the atorvastatin-treated group the cell apoptosis rate was reduced and the endoplasmic reticulum (ER) stress was activated in response to heart failure and angiotensin II(Ang II) stimulation.</p><p><b>Conclusions</b>: By down-regulating GRP78, caspase-12 and CHOP expressions in myocardial cells in rat heart failure after myocardial infarction, atorvastatin treatment decreased the apoptosis of myocardial cells, suggesting the possible mechanism by which atorvastatin functions in protecting against heart failure.</p> ]]></description>  
<dc:creator>Xian Jing Song, Chun Yan Yang, Bin Liu, Qun Wei, Melvin T. Korkor, Jie Yu Liu, Ping Yang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>564</prism:startingPage> 
<prism:endingPage>572</prism:endingPage> 
<pubDate>2011-9-22</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0558.htm</link> 
<title>Multicentric Epithelioid Hemangioendothelioma Involving the Same Lower Extremity: A Case Report and Review of Literature</title> 
<description><![CDATA[ <p>Epithelioid hemangioendothelioma (EH) is an uncommon low-grade malignant soft-tissue tumor; no case has been previously reported where multicentric epithelioid hemangioendothelioma occurred in the same lower extremity at different sites. We report a case involving the common peroneal nerve and subsequently the long bone and the short bones of the same lower extremity, and also review the literature. After establishing case of several lesions, we reviewed the histopathology properly and followed up the patient for a long time with serial whole body assessment to pick up any subsequent lesions.</p> ]]></description>  
<dc:creator>Qingjun Liu, Jianyun Miao, Kejian Lian, Lianshui Huang, Zhenqi Ding</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>558</prism:startingPage> 
<prism:endingPage>563</prism:endingPage> 
<pubDate>2011-9-22</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0554.htm</link> 
<title>Risk Factors of Neonatal Anemia in Placenta Previa</title> 
<description><![CDATA[ <p><b>Objectives: </b>Placenta previa is a major cause of neonatal anemia. The purpose of this study was to elucidate the risk factors of neonatal anemia in placenta previa.</p><p><b>Methods: </b>The study was conducted on 158 placenta previa patients at 3 hospitals in affiliation with the Catholic Medical Center, Seoul, Korea from May 1999 through December 2009. The subjects were divided in to 2 groups: 47 placenta previa patients with neonatal anemia, and 113 placenta previa patients without neonatal anemia. The subjects' characteristics were compared. Logistic regression was used to control for confounding factors.</p><p><b>Results:</b> Anterior placental location (OR 2.48; 95% CI: 1.20-5.11) was an independent risk factor of neonatal anemia after controlling for potential confounders.</p><p><b>Conclusion:</b> To manage neonatal anemia in placenta previa patients, obstetricians should do their best to detect placental location. Pediatricians should consider the high possibility of neonatal anemia in cases involving anterior placental location.</p> ]]></description>  
<dc:creator>Dong Gyu Jang, Yun Sung Jo, Sung Jong Lee, Gui Se Ra Lee</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>554</prism:startingPage> 
<prism:endingPage>557</prism:endingPage> 
<pubDate>2011-9-19</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0547.htm</link> 
<title>Iatrogenic Mandibular Fracture Associated with Third Molar Removal</title> 
<description><![CDATA[ <p>Third molar extraction is one of the most common procedures performed in oral and maxillofacial surgery units. It is sometimes accompanied by complications such as alveolar osteitis, secondary infection, hemorrhage, dysesthesia and, most severely, iatrogenic fracture. This article describes two mandibular angle fractures that occurred in two patients during the surgical extraction of one erupted and one unerupted third molar, including a brief review of the literature.</p> ]]></description>  
<dc:creator>Abdulkadir Burak Cankaya, Mehmet Ali Erdem, Sirmahan Cakarer, Muhsin Cifter, Cuneyt Korhan Oral</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>547</prism:startingPage> 
<prism:endingPage>553</prism:endingPage> 
<pubDate>2011-9-17</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0540.htm</link> 
<title>Evaluation of QT and P Wave Dispersion and Mean Platelet Volume among Inflammatory Bowel Disease Patients</title> 
<description><![CDATA[ <p><b>Background</b>: In inflammatory bowel disease (IBD) number of thromboembolic events are increased due to hypercoagulupathy and platelet activation. Increases in mean platelet volume (MPV) can lead to platelet activation, this leads to thromboembolic events and can cause acute coronary syndromes. In IBD patients, QT-dispersion and P-wave dispersion are predictors of ventricular arrhythmias and atrial fibrilation; MPV is accepted as a risk factor for acute coronary syndromes, we aimed at evaluating the correlations of these with the duration of disease, its localization and activity.</p><p><b>Methods</b>: The study group consisted of 69 IBD (Ulcerative colitis n: 54, Crohn's Disease n:15) patients and the control group included 38 healthy individuals. Disease activity was evaluated both endoscopically and clinically. Patients with existing cardiac conditions, those using QT prolonging medications and having systemic diseases, anemia and electrolyte imbalances were excluded from the study. QT-dispersion, P-wave dispersion and MPV values of both groups were compared with disease activity, its localization, duration of disease and the antibiotics used.</p><p><b>Results</b>: The P-wave dispersion values of the study group were significantly higher than those of the control group. Duration of the disease was not associated with QT-dispersion, and MPV levels. QT-dispersion, P-wave dispersion, MPV and platelet count levels were similar between the active and in mild ulcerative colitis patients. QT-dispersion levels were similar between IBD patients and the control group. No difference was observed between P-wave dispersion, QT-dispersion and MPV values; with regards to disease duration, disease activity, and localization in the study group (p&#62;0.05).</p><p><b>Conclusions</b>: P-wave dispersion which is accepted as a risk factor for the development of atrial fibirilation was found to be high in our IBD patients. This demonstrates us that the risk of developing atrial fibrillation may be high in patients with IBD. No significant difference was found in the QT-dispersion, and in the MPV values when compared to the control group.</p> ]]></description>  
<dc:creator>Yuksel DOGAN, Aliye SOYLU, Gulay A. EREN, Sule POTUROGLU, Can DOLAPCIOGLU, Kenan SONMEZ, Habibe DUMAN, Isa SEVINDIR</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>540</prism:startingPage> 
<prism:endingPage>546</prism:endingPage> 
<pubDate>2011-9-16</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0537.htm</link> 
<title>A Rare Cause of Bacteremia in a Pediatric Patient with Down Syndrome: Sphingomonas Paucimobilis</title> 
<description><![CDATA[ <p><i>Sphingomonas paucimobilis, </i>is a yellow-pigmented, aerobic, non fermentative, gram negative motile bacillus. <i>S. paucimobilis </i>which is widely found in nature and hospital environments rarely cause serious or life threatening infections. In this report, a case of hospital acquired bloodstream infection due to <i>S. paucimobilis </i>in a patient with Down syndrome who was on treatment for presumed pneumonia is presented.</p><p><i>A</i> one year-old child patient who was a known case of Down syndrome and had previously experienced cardiac surgery was hospitalized and treated for pneumonia. On the 12th day of hospitalization, blood cultures were taken because of a high body temperature. One of the blood cultures was positive for gram-negative rods. After 48 hour of incubation, the sub-cultures on blood agar medium yielded pure growth of a yellow, non-fermentative, gram-negative, rod-shaped bacterium. The microorganism was positive for oxidase, and esculin hydrolysis, while negative for urea and nitrate reduction, citrate utilisation and motility. The isolate had been identified as <i>S. paucimobilis</i> by using Vitek 2 system. The antibiotic susceptibility test was also performed with the same system and the strain was found to be susceptible to piperacillin-tazobactam and other antibiotics. Treatment with intravenous piperacilin-tazobactam (150 mg/kg/day) was initiated. He responded well to the treatment and was discharged after 10 days. This case is reported to emphasize that <i>S. paucimobilis</i> should be kept in mind as a nosocomial infectious agent in patients with Down syndrome and immunosuppressive patients and the infections should be treated according to the sensitivity test results.</p> ]]></description>  
<dc:creator>Mehmet &#214;zdemir, Sevgi Pekcan, Mehmet Emin Demircili, Fatma Esenkaya Ta&#351;bent, Bahad&#305;r Feyzio&#287;lu, &#350;erife Pirin&#231;, Mahmut Baykan</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>537</prism:startingPage> 
<prism:endingPage>539</prism:endingPage> 
<pubDate>2011-9-14</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0529.htm</link> 
<title>The Clinical Significance of Digital Examination-Indicated Cerclage in Women with a Dilated Cervix at 14 0/7 - 29 6/7 Weeks</title> 
<description><![CDATA[ <p><b>Objective. </b>This study was to compare pregnancy outcomes between cerclage and expectant management in wemen with a dilated cervix. <b>Design</b>. Retrospective multicenter cohort study. <b>Setting.</b> Five hospitals of Catholic University Medical Center Network in Korea. <b>Population.</b> A total of 173 women between 14 0/7 and 29 6/7 weeks' gestation with cervical dilation of 1 cm or greater by digital examination. <b>Methods.</b> Pregnancy outcomes were compared according to cerclage or expectant management, with the use of propensity-score matching. <b>Main Outcome Measures.</b> Primary outcome was time from presentation until delivery (weeks). Secondary outcomes were gestational age at delivery, neonatal survival, morbidity, preterm birth, and so on.</p><p><b>Results.</b> Of 173 women, 116 received a cerclage (cerclage group), and 57 were managed expectantly without cerclage (expectant group). Cervical dilation at presentation, and the use of amniocentesis performed to exclude subclinical chorioamnionitis differed between two groups. In the overall matched cohort, there was significant difference in the time from presentation until delivery (cerclage vs. expectant group, 10.6&#177;6.2 vs. 2.9&#177;3.2 weeks, p &#60;0.0001). While there was no significant difference in the neonatal survival between two groups, there werelower neonatal morbidity as well as higher pregnancy maintenance rate at 28, 32, 34 and 37 weeks' gestation in the cerclage group, compared with the expectant group.</p><p><b>Conclusion</b>. This study suggests that digital examination-indicated cerclage appears to prolong gestation and decrease neonatal morbidity, compared with expectant management in women with cervical dilation between 14 0/7 and 29 6/7 weeks.</p> ]]></description>  
<dc:creator>Hyun Sun Ko, Yun Seong Jo, Ki Cheol Kil, Ha Kyun Chang, Yong-Gyu Park, In Yang Park, Guisera Lee, Sajin Kim, Jong Chul Shin</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>529</prism:startingPage> 
<prism:endingPage>536</prism:endingPage> 
<pubDate>2011-9-6</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0523.htm</link> 
<title>Methylenetetrahydrofolate Reductase Gene Polymorphisms in Children with Attention Deficit Hyperactivity Disorder</title> 
<description><![CDATA[ <p><b>Objective</b>: The purpose of this study was to evaluate the relationship between 5,10- methylenetetrahydrofolate reductase (MTHFR) polymorphisms and Attention Deficit Hyperactivity Disorder (ADHD) in a sample of Turkish children.</p><p><b>Study Design:</b> MTHFR gene polymorphisms were assessed in 40 patients with ADHD and 30 healty controls. Two mutations in the MTHFR gene were investigated using polymerase chain reactions and restriction fragment length polymorphisms.</p><p><b>Results</b>: Although there were no statistically significant differences in genotype distributions of the C677T alleles between the ADHD and the control groups (p=0,678) but the genotypic pattern of the distributions of the A1298C alleles was different between the ADHD patients and the controls (p=0,033).</p><p><b>Conclusions: </b>Preliminary data imply a possible relationship between A1298C MTHFR polymorphisms and the ADHD.</p> ]]></description>  
<dc:creator>Cem Gokcen, Nadir Kocak, Ahmet Pekgor</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>523</prism:startingPage> 
<prism:endingPage>528</prism:endingPage> 
<pubDate>2011-8-30</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0514.htm</link> 
<title>Impairment of Pulmonary Function is an Independent Risk Factor for Atrial Fibrillation: The Takahata Study</title> 
<description><![CDATA[ <p><b>Background: </b>Chronic pulmonary disorders, such as chronic obstructive pulmonary disease (COPD) and fibrosing lung diseases, and atrial fibrillation (AF), are prevalent in elderly people. The impact of cardiac co-morbidities in the elderly, where pulmonary function is impaired, cannot be ignored as they influence mortality. The relationship between the prevalence of AF and pulmonary function is unclear. The aim of this study was to evaluate this relationship in participants in a health check.</p><p><b>Methods: </b>Subjects aged 40 or older (n = 2,917) who participated in a community-based annual health check in Takahata, Japan, from 2004 through to 2005, were enrolled in the study. We performed blood pressure measurements, blood sampling, electrocardiograms, and spirometry on these subjects.</p><p><b>Results: </b>The mean FEV<sub>1</sub> % predicted and FVC % predicted in AF subjects was significantly lower than in non-AF subjects. The prevalence of AF was higher in those subjects with airflow limitation or lung restriction than in those without. Furthermore, AF prevalence was higher in those subjects with severe airflow obstruction (FEV<sub>1</sub> %predicted &#60; 50) than in those who had mild or moderate airflow obstruction (FEV<sub>1</sub> %predicted &#8805; 50), although there was no difference between the prevalence of AF in subjects with 70&#8804; FVC %predicted &#60;80 lung restriction and those with FVC %predicted &#60;70. Multiple logistic regression analysis revealed that FEV<sub>1</sub> %predicted and FVC %predicted are independent risk factors for AF (independent of age, gender, left ventricular hypertrophy, and serum levels of B-type natriuretic peptide).</p><p><b>Conclusion: </b>Impaired pulmonary function is an independent risk factor for AF in the Japanese general population.</p> ]]></description>  
<dc:creator>Yoko Shibata, Tetsu Watanabe, Daisuke Osaka, Shuichi Abe, Sumito Inoue, Yoshikane Tokairin, Akira Igarashi, Keiko Yamauchi, Tomomi Kimura, Hiroyuki Kishi, Yasuko Aida, Keiko Nunomiya, Takako Nemoto, Masamichi Sato, Tsuneo Konta, Sumio Kawata, Takeo Kato, Takamasa Kayama, Isao Kubota</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>7</prism:number> 
<prism:startingPage>514</prism:startingPage> 
<prism:endingPage>522</prism:endingPage> 
<pubDate>2011-8-29</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0510.htm</link> 
<title>A Case Report on Eosinophilic Meningitis Caused by Angiostrongylus cantonensis</title> 
<description><![CDATA[ <p><i>Angiostrongylus cantonensis</i> is the most common cause of eosinophilic meningitis in humans. It is usually caused by ingestion of raw or inadequately cooked intermediate hosts or food contaminated with infective third-stage larvae. We describe a case of eosinophilic meningitis caused by <i>A. cantonensis</i> in a male Chinese patient. The patient had a history of eating raw fish and snail. We describe the clinical features of the patient, the diagnostic process and treatments. We also provide a brief update for physicians on the characteristics, diagnosis and treatment of eosinophilic meningitis caused by <i>A. cantonensis</i>, with particular emphasis on the update of prevalence and treatment of the disease in China.</p> ]]></description>  
<dc:creator>Jingyao Liu, Jiguo Gao, Chunkui Zhou</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>510</prism:startingPage> 
<prism:endingPage>513</prism:endingPage> 
<pubDate>2011-8-27</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0501.htm</link> 
<title>Oral Rehydration Therapy for Preoperative Fluid and Electrolyte Management</title> 
<description><![CDATA[ <p><b>Aim: </b>Preoperative fluid and electrolyte management is usually performed by intravenous therapy. We investigated the safety and effectiveness of oral rehydration therapy (ORT) for preoperative fluid and electrolyte management of surgical patients.</p><p><b>Methods:</b> The study consisted of two studies, designed as a prospective observational study. In a pilot study, 20 surgical patients consumed 1000 mL of an oral rehydration solution (ORS) until 2 h before induction of general anesthesia. Parameters such as serum electrolyte concentrations, fractional excretion of sodium (FENa) as an index of renal blood flow, volume of esophageal-pharyngeal fluid and gastric fluid (EPGF), and patient satisfaction with ORT were assessed. In a follow-up study to assess the safety of ORT, 1078 surgical patients, who consumed ORS until 2 h before induction of general anesthesia, were assessed.</p><p><b>Results:</b> In the pilot study, water, electrolytes, and carbohydrate were effectively and safely supplied by ORT. The FENa value was increased at 2 h following ORT. The volume of EPGF collected following the induction of anesthesia was 5.3&#177;5.6 mL. In the follow-up study, a small amount of vomiting occurred in one patient, and no aspiration occurred in the patients.</p><p><b>Conclusion:</b> These results suggest that ORT is a safe and effective therapy for the preoperative fluid and electrolyte management of selected surgical patients.</p> ]]></description>  
<dc:creator>Hideki Taniguchi, Toshio Sasaki, Hisae Fujita</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>501</prism:startingPage> 
<prism:endingPage>509</prism:endingPage> 
<pubDate>2011-8-25</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0492.htm</link> 
<title>Translational Medicine and Reliability of Single-Nucleotide Polymorphism Studies: Can We Believe in SNP Reports or Not?</title> 
<description><![CDATA[ <p><b>Background:</b> The number of genetic association studies is increasing exponentially. Nonetheless, genetic association reports are prone to potential biases which may influence the reported outcome.</p><p><b>Aim:</b> We hypothesized that positive outcome for a determined polymorphism might be over-reported across genetic association studies analysing a small number of polymorphisms, when compared to studies analysing the same polymorphism together with a high number of other polymorphisms.</p><p><b>Methods</b>: We systematically reviewed published reports on the association of glutathione s-transferase (GST) single-nucleotide polymorphisms (SNPs) and cancer outcome.</p><p><b>Result:</b> We identified 79 eligible trials. Most of the studies examined the GSTM1, theGSTP1 Ile105Val mutation, and GSTT1polymorphisms (n = 54, 57 and 46, respectively). Studies analysing one to three polymorphisms (n = 39) were significantly more likely to present positive outcomes, compared to studies examining more than 3 polymorphisms (n=40) p = 0.004; this was particularly evident for studies analysing the GSTM1polymorphism (p =0.001). We found no significant associations between journal impact factor, number of citations, and probability of publishing positive studies or studies with 1-3 polymorphisms examined.</p><p><b>Conclusions</b>: We propose a new subtype of publication bias in genetic association studies. Positive results for genetic association studies analysing a small number of polymorphisms (n = 1-3) should be evaluated extremely cautiously, because a very large number of such studies are inconclusive and statistically under-powered. Indeed, publication of misleading reports may affect harmfully medical decision-making and use of resources, both in clinical and pharmacological development setting.</p> ]]></description>  
<dc:creator>Antonis Valachis, Davide Mauri, Christodoulos Neophytou, Nikolaos P. Polyzos, Lampriani Tsali, Antonios Garras, Evangelos G. Papanikolau</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>492</prism:startingPage> 
<prism:endingPage>500</prism:endingPage> 
<pubDate>2011-8-24</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0487.htm</link> 
<title>Adverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations</title> 
<description><![CDATA[ <p><b>Objective:</b> Adverse event reports (AERs) submitted to the US Food and Drug Administration (FDA) were reviewed to confirm platinum agent-associated adverse events, and to clarify the rank-order of these drugs in terms of susceptibility.</p><p><b>Methods:</b> After a revision of arbitrary drug names and the deletion of duplicated submissions, AERs involving cisplatin (CDDP), carboplatin (CBDCA), or oxaliplatin (L-OHP) were analyzed. Authorized pharmacovigilance tools were used for the quantitative detection of signals, i.e., drug-associated adverse events, including the proportional reporting ratio, the reporting odds ratio, the information component given by a Bayesian confidence propagation neural network, and the empirical Bayes geometric mean.</p><p><b>Results:</b> Based on 1,644,220 AERs from 2004 to 2009, CDDP, CBDCA, and L-OHP all proved to cause nausea, vomiting, acute renal failure, neutropenia, thrombocytopenia, and peripheral sensory neuropathy. Higher susceptibility to nausea was found for CDDP than CBDCA and L-OHP. Acute renal failure was also more predominant for CDDP, and CBDCA did not increase the blood level of creatinine. A stronger association with thrombocytopenia was suggested for CBDCA. Susceptibility to peripheral sensory neuropathy was greatest for L-OHP, but less extensive for CDDP and CBDCA.</p><p><b>Conclusion:</b> The results obtained herein were consistent with clinical observations, suggesting the usefulness of the FDA's adverse event reporting system, AERS, and the data mining method used herein.</p> ]]></description>  
<dc:creator>Toshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>487</prism:startingPage> 
<prism:endingPage>491</prism:endingPage> 
<pubDate>2011-8-16</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0482.htm</link> 
<title>A Voxel-based Morphometric Analysis of Cerebral Gray Matter in Subcortical Ischemic Vascular Dementia Patients and Normal Aged Controls</title> 
<description><![CDATA[ <p><b>BACKGROUND AND PURPOSE:</b> The present study was designed to detect the abnormalities of the cerebral grey-matter density in subcortical ischemic vascular dementia patients by FSL-VBM method to promote the early diagnosis of it.</p><p><b>METHODS: </b>Nine subcortical ischemic vascular dementia patients and nine age-matched normal controls underwent MRI brain structure scanning that was performed on a SIEMENS AVANTO 1.5 Tesla scanner and standard T1-weighted high-resolution anatomic scans of MPRAGE sequence were obtained. The 3-demensional MPRAGE images were processed with FSL-VBM package and the cerebral gray matter density was compared between the subcortical ischemic vascular dementia patients and normal controls.</p><p><b>RESULTS:</b> Compared with the normal control group, the cerebral gray matter density of subcortical ischemic vascular dementia patients was found significantly decreasing, including brain regions of thalamus, parietal lobe, frontal lobe and temporal lobe (<i>P</i>&#60;0.05).</p><p><b>CONCLUSIONS:</b> The cerebral gray matter density alterations have closed correlation with cognitive dysfunction in subcortical ischemic vascular dementia patient and can be detected by MRI. MRI has some potential value in the diagnosis of them.</p> ]]></description>  
<dc:creator>Chuanming Li, Hanjian Du, Jian Zheng, Jian Wang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>482</prism:startingPage> 
<prism:endingPage>486</prism:endingPage> 
<pubDate>2011-8-13</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0479.htm</link> 
<title>Spindle Cell Lipoma of the Hypopharynx</title> 
<description><![CDATA[ <p><b>Objective</b>: We report a rare case of a spindle cell lipoma with atypical clinical course.</p><p><b>Case report</b>: A 51 year old female patient referred to our clinic with feeling of mass in the throat she had had for two years. The patient described difficulty in swallowing. Indirect laryngoscopy did not reveal any masses at bilateral pyriform sinuses, and the mucosa had a natural appearance. However, a mass with a stalk was detected in the side of the mouth when the patient retched. Endoscopic monitoring of the mass revealed its origin to be the left sinus pyriformis. No pathological structures could be detected in the indirect laryngoscopy taken after the patient gulped again. The mass was shown by magnetic resonance imaging to extend into the esophagus. It was removed using suspension microlaryngoscopy. Postoperative control revealed a complete healing at the excision site. Immunohistochemical examination for pathological diagnosis indicated a spindle cell lipoma.</p><p><b>Conclusions</b>: Laryngeal and hypopharyngeal lipomas are rare forms of benign laryngeal neoplasms. Their asymptomatic course makes diagnosis difficult. The patient is presented here with related clinical and pathological features.</p> ]]></description>  
<dc:creator>Muhammed Fatih Evcimik, Fazil Emre Ozkurt, Tarik Sapci, Ziya Bozkurt</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>479</prism:startingPage> 
<prism:endingPage>481</prism:endingPage> 
<pubDate>2011-8-6</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0470.htm</link> 
<title>The Relationship between Serum Uric Acid and Spirometric Values in Participants in a Health Check: The Takahata Study</title> 
<description><![CDATA[ <p><b>Background: </b>Tissue hypoxia induces the degradation of adenosine triphosphate, resulting in the production of uric acid (UA). Patients with chronic obstructive pulmonary disease (COPD) have been reported to have high serum levels of UA (sUA), compared with control subjects. However, the relationship between sUA levels and spirometric measures has not been investigated in detail in a general population.</p><p><b>Methods: </b>Subjects aged 40 years or older (n = 2,917), who had participated in a community-based annual health check in Takahata, Japan, in 2004 and 2005, were enrolled in the study. These subjects performed spirometry, their blood pressure was measured, and a blood sample was taken.</p><p><b>Results: </b>sUA levels were significantly higher in males than in females. Percent predicted forced vital capacity [FVC %predicted] (<i>r</i> = -0.13) and forced expiratory volume in 1 s [FEV<sub>1</sub> %predicted] (<i>r</i> = -0.118) were inversely correlated with sUA levels in females but not in males. Univariate regression analysis indicated that age, body mass index (BMI), ethanol intake, mean blood pressure (BP), and serum creatinine (sCr) were significantly associated with sUA levels in males. In females, age, BMI, mean BP, hemoglobin A1c, sCr, FVC %predicted, and FEV<sub>1</sub> %predicted were significantly associated with sUA levels. Multiple linear regression analysis showed that for both genders, FVC %predicted and FEV<sub>1</sub> %predicted were predictive for sUA levels, independently of the other clinical parameters. Subjects with lung restriction had higher sUA levels than subjects without lung restriction. In addition, subjects with moderate and severe airflow limitation had higher sUA levels than subjects without airflow limitation or those with mild airflow limitation.</p><p><b>Conclusion: </b>FVC %predicted and FEV<sub>1</sub> %predicted were significantly associated with sUA levels in a general population.</p> ]]></description>  
<dc:creator>Yasuko Aida, Yoko Shibata, Daisuke Osaka, Shuichi Abe, Sumito Inoue, Koji Fukuzaki, Yoshikane Tokairin, Akira Igarashi, Keiko Yamauchi, Takako Nemoto, Keiko Nunomiya, Hiroyuki Kishi, Masamichi Sato, Tetsu Watanabe, Tsuneo Konta, Sumio Kawata, Takeo Kato, Isao Kubota</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>470</prism:startingPage> 
<prism:endingPage>478</prism:endingPage> 
<pubDate>2011-8-5</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0467.htm</link> 
<title>Spontaneous Hemoperitoneum Caused By a Diverticulum of the Sigmoid Colon</title> 
<description><![CDATA[ <p>The diverticulum of the sigmoid colon is relatively common in the gastrointestinal tract, with the majority of cases being asymptomatic. A non-traumatic hemoperitoneum secondary to colonic diverticulum is very rare. Here, we report the case of a 35-year-old woman with hemoperitoneum caused by the bleeding of the serosal vessel of the sigmoid colon diverticulum. The bleeding focus was identified and ligated, and the diverticulum was invaginated laparoscopically. No blood vessel malformation was detected.</p> ]]></description>  
<dc:creator>Bong Hyeon Kye, Hyung Jin Kim, Joo Hee Yoon, Dong Choon Park, Sung Jong Lee</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>467</prism:startingPage> 
<prism:endingPage>469</prism:endingPage> 
<pubDate>2011-8-3</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0461.htm</link> 
<title>Patient Specification Quality Assurance for Glioblastoma Multiforme Brain Tumors Treated with Intensity Modulated Radiation Therapy</title> 
<description><![CDATA[ <p>The aim of this study was to evaluate the significance of performing patient specification quality assurance for patients diagnosed with glioblastoma multiforme treated with intensity modulated radiation therapy. The study evaluated ten intensity modulated radiation therapy treatment plans using 10 MV beams, a total dose of 60 Gy (2 Gy/fraction, five fractions a week for a total of six weeks treatment). For the quality assurance protocol we used a two-dimensional ionization-chamber array (2D-ARRAY). The results showed a very good agreement between the measured dose and the pretreatment planned dose. All the plans passed &#62;95% gamma criterion with pixels within 5% dose difference and 3 mm distance to agreement. We concluded that using the 2D-ARRAY ion chamber for intensity modulated radiation therapy is an important step for intensity modulated radiation therapy treatment plans, and this study has shown that our treatment planning for intensity modulated radiation therapy is accurately done.</p> ]]></description>  
<dc:creator>H. I. Al-Mohammed</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>461</prism:startingPage> 
<prism:endingPage>466</prism:endingPage> 
<pubDate>2011-8-2</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0456.htm</link> 
<title>Trace Elements, Heavy Metals and Vitamin Levels in Patients with Coronary Artery Disease</title> 
<description><![CDATA[ <p><b>Aim:</b> In the present study, we aimed to assess serum concentrations of zinc (Zn), copper (Cu), iron (Fe), cadmium (Cd), lead (Pb), manganese (Mn), vitamins A (retinol), D (cholecalciferol) and E (&#945;-tocopherol) in patients with coronary artery disease (CAD) and to compare with healthy controls.</p><p><b>Methods</b>: A total of 30 CAD patients and 20 healthy subjects were included in this study. Atomic absorption spectrophotometry (UNICAM-929) was used to measure heavy metal and trace element concentrations. Serum &#945;-tocopherol, retinol and cholecalciferol were measured simultaneously by high performance liquid chromatography (HPLC).</p><p><b>Results:</b> Demographic and baseline clinical characteristics were not statistically different between the groups. Serum concentrations of retinol (0.3521&#177;0.1319 vs. 0.4313&#177;0.0465 mmol/I, p=0.013), tocopherol (3.8630&#177;1.3117 vs. 6.9124&#177;1.0577 mmol/I, p&#60;0.001), cholecalciferol (0.0209&#177;0.0089 vs. 0.0304&#177;0.0059 mmol/I, p&#60;0.001) and Fe (0.5664&#177;0.2360 vs. 1.0689&#177;0,4452 &#181;g/dI, p&#60;0.001) were significantly lower in CAD patients. In addition, while not statistically significant serum Cu (1.0164&#177;0.2672 vs. 1.1934&#177;0.4164 &#181;g/dI, p=0.073) concentrations were tended to be lower in patients with CAD, whereas serum lead (0.1449&#177;0.0886 vs. 0.1019&#177;0.0644 &#181;g/dI, p=0.069) concentrations tended to be higher.</p><p><b>Conclusions</b>: Serum level of trace elements and vitamins may be changed in patients with CAD. In this relatively small study we found that serum levels of retinol, tocopherol, cholecalciferol, iron and copper may be lower whereas serum lead concentrations may be increased in patients with CAD.</p> ]]></description>  
<dc:creator>Aysegul Cebi, Yuksel Kaya, Hasan Gungor, Halit Demir, Ibrahim Hakki Yoruk, Nihat Soylemez, Yilmaz Gunes, Mustafa Tuncer</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>456</prism:startingPage> 
<prism:endingPage>460</prism:endingPage> 
<pubDate>2011-8-2</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0453.htm</link> 
<title>Evaluation of the Prevalence of Concomitant Idiopathic Cyclic Edema and Cellulite</title> 
<description><![CDATA[ <p>The aim of this study was to evaluate the prevalence of concomitant idiopathic cyclic edema with Grade II and III cellulite. All patients treated for Grade II and III cellulite were evaluated for idiopathic cyclic edema in a retrospective, quantitative and cross-sectional study. The study was carried out at the Godoy Clinic in the period from 2006 to 2010. All patients with body mass indexes &#62; 25, Grade I cellulite and other causes of edema were excluded. The diagnosis of idiopathic cyclic edema was based on a clinical history and fluid retention throughout the day, in particular difficulty in removing rings on waking in the morning which improves later in the day. All patients with cyclic edema were treated with 75 mg aminaphtone three times daily. Statistical analysis considered the frequency of edema.</p><p>Of the 82 women evaluated with ages between 18 and 58 years old (mean of 34.9 years) 41 (50.0%) were diagnosed with idiopathic cyclic edema.</p><p>Idiopathic cyclic edema is an aggravating factor for cellulite and is frequently associated with the more advanced stages of the disease. Its control is essential in the treatment of cellulite.</p> ]]></description>  
<dc:creator>Jos&#233; Maria Pereira de Godoy, Maria de F&#225;tima Guerreiro de Godoy</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>453</prism:startingPage> 
<prism:endingPage>455</prism:endingPage> 
<pubDate>2011-8-2</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0445.htm</link> 
<title>Effect of Weight Reduction on Cardiovascular Risk Factors and CD34-positive Cells in Circulation</title> 
<description><![CDATA[ <p>Being overweight or obese is associated with an increased risk for the development of non-insulin-dependent diabetes mellitus, hypertension, and cardiovascular disease. Dyslipidemia of obesity is characterized by elevated fasting triglycerides and decreased high-density lipoprotein-cholesterol concentrations. Endothelial damage and dysfunction is considered to be a major underlying mechanism for the elevated cardiovascular risk associated with increased adiposity. Alterations in endothelial cells and stem/endothelial progenitor cell function associated with overweight and obesity predispose to atherosclerosis and thrombosis.</p><p>In our study, we analyzed the effect of a low calorie diet in combination with oral supplementation by vitamins, minerals, probiotics and human chorionic gonadotropin (hCG, 125-180 IUs) on the body composition, lipid profile and CD34-positive cells in circulation.</p><p>During this dieting program, the following parameters were assessed weekly for all participants: fat free mass, body fat, BMI, extracellular/intracellular water, total body water and basal metabolic rate. For part of participants blood chemistry parameters and circulating CD34-positive cells were determined before and after dieting.</p><p>The data indicated that the treatments not only reduced body fat mass and total mass but also improved the lipid profile. The changes in body composition correlated with the level of lipoproteins responsible for the increased cardiovascular risk factors. These changes in body composition and lipid profile parameters coincided with the improvement of circulatory progenitor cell numbers.</p><p>As the result of our study, we concluded that the improvement of body composition affects the number of stem/progenitor cells in circulation.</p> ]]></description>  
<dc:creator>Nina A Mikirova, Joseph J Casciari, Ronald E Hunninghake, Margaret M Beezley</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>6</prism:number> 
<prism:startingPage>445</prism:startingPage> 
<prism:endingPage>452</prism:endingPage> 
<pubDate>2011-8-1</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0439.htm</link> 
<title>Maternal Outcomes According to Placental Position in Placental Previa</title> 
<description><![CDATA[ <p><b>Purpose: </b>The purpose of this retrospective cohort study was to elucidate whether the location of placenta below uterine incision in cesarean section is important in the development of maternal complications in placenta previa patients.</p><p><b>Methods: </b>The study was conducted on 409 patients 414 parturition at 3 hospitals in affiliation with the Catholic Medical Center, Seoul, Korea from May 1999 to December 2009. The subjects were divided to two groups: the group whose placenta was located in the anterior portion of the uterus (anterior group) and the group whose placenta was located in the posterior portion of the uterus (posterior group). And then they are compared to each other. Logistic regression was used to control for confounding factors.</p><p><b>Results: </b>In the anterior group, regardless of confounding factors, the incidence of excessive blood loss (OR 2.97; 95% CI: 1.64-5.37), massive transfusion (OR 3.31; 95% CI: 1.33-8.26), placental accreta (OR 2.60, 95% CI: 1.40-4.83), and hysterectomy (OR 3.47, 95% CI: 1.39-8.68) was higher.</p><p><b>Conclusion: </b>Sonographic determination of the placental position where its location beneath the uterine incision is very important to predict maternal outcomes in placenta previa patients, and such cases, close attention should be paid for massive hemorrhage.</p> ]]></description>  
<dc:creator>Dong Gyu Jang, Ji Sun We, Jae Un Shin, Yun Jin Choi, Hyun Sun Ko, In Yang Park, Jong Chul Shin</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>439</prism:startingPage> 
<prism:endingPage>444</prism:endingPage> 
<pubDate>2011-7-23</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0433.htm</link> 
<title>Lack of Preemptive Analgesia by Intravenous Flurbiprofen in Thyroid Gland Surgery: A Randomized, Double-blind and Placebo-controlled Clinical Trial</title> 
<description><![CDATA[ <p><b>Background</b> Nowadays, increasingly more preemptive analgesia studies focus on postoperative pain; however, the impact of preemptive analgesia on perioperative opioid requirement is not well defined. This study was carried out in order to evaluate whether preoperative intravenous flurbiprofen axetil can reduce perioperative opioid consumption and provide postoperative analgesia in patients undergoing thyroid gland surgery.</p><p><b>Methods </b>Ninety patients undergoing elective thyroid gland surgery were randomly assigned to three groups. Group A (Control) was administered Intralipid<sup>&#174;</sup> 2 ml as a placebo 15 min before the cervical plexus block and at the end of the surgery; Group B (Routine analgesia) was administered a placebo 15 min before the cervical plexus block and flurbiprofen 50 mg at the end of the surgery; Group C (Preemptive analgesia) was administered intravenous flurbiprofen 50 mg 15 min before the cervical plexus block and a placebo at the end of the surgery. Sufentanil administration during the surgery and the 24 h satisfaction score on analgesic therapy were both recorded. The analgesic efficacy was assessed at 1, 2, 4, 6, 8, 12, and 24 hours after the surgery, based on visual analog scales.</p><p><b>Results</b> Ninety patients were involved in the study. One patient from Group B did not have their scheduled surgery; eighty-nine patients completed the study. There were no significant differences in the patient demographics between the three groups. Visual analog scales: 1, 2, 4 h for Group A was significantly higher than Groups B and C (<i>P</i>&#60;0.05); Sufentanil administration during surgery: Group C was obviously lower compared to Groups A and B (<i>P</i>&#60;0.05); 24 h satisfaction score: Groups B and C were higher than Group A (<i>P</i>&#60;0.05).</p><p><b>Conclusion </b>Preoperative administration of intravenous Flurbiprofen axetil reduced analgesic consumption during surgery, but not postoperative pain scores.</p> ]]></description>  
<dc:creator>Zhaodi Zhang, Haifang Zhao, Changsong Wang, Fei Han, Guonian Wang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>433</prism:startingPage> 
<prism:endingPage>438</prism:endingPage> 
<pubDate>2011-7-15</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0428.htm</link> 
<title>A Comparison of Immuncapture Agglutination and ELISA Methods in Serological Diagnosis of Brucellosis</title> 
<description><![CDATA[ <p><b>Background: </b>Different serological tests are used in serologic diagnosis of brucellosis. The most widely used of these are Standard Tube Agglutination and Coombs anti-brucella tests. Whereas ELISA Ig M and Ig G tests have been in use for a long time, immuncapture agglutination test has been recently introduced and used in serological diagnosis. The aim of this study was to compare diagnostic values of ELISA Ig M and Ig G and immuncapture agglutination tests with Coombs anti-brucella test.</p><p><b>Methods:</b> Sera from 200 patients with presumptive diagnosis of brucellosis were included into the study. Coombs anti-brucella test, ELISA Ig M and Ig G tests and Immuncapture test were investigated in these sera. Then, sensitivity, specificity, negative predictive and positive predictive values were calculated.</p><p><b>Results:</b> Sensitivity, specificity, negative predictive and positive predictive values were found to be 90,6 %, 76,3 %, 94,2 %, and 65,9 % respectively for the Immuncapture test, whereas they were found to be 73,7 %, 58,9 %, 84,2 %, and 42,8 % for Ig G and 72,2 %, 67,8 %, 85,2 %, and 48,7 % for Ig M. The Immuncapture test was found to be compatible with ELISA Ig M and Ig G tests but it was statistically incompatible with Coombs anti-brucella test.</p><p><b>Conclusions:</b> Immuncapture agglutination test yields similar results to those of Coombs anti-brucella test. This test is a useful test by virtue of the fact that it determines blocking antibodies in the diagnosis and follow-up of brucellosis.</p> ]]></description>  
<dc:creator>Mehmet &#214;zdemir, Bahad&#305;r Feyzio&#287;lu, Muhammed G&#252;zel Kurto&#287;lu, Metin Do&#287;an, Hatice T&#252;rk Da&#287;&#305;, &#350;erife Y&#252;ksekkaya, Recep Ke&#351;li, B&#252;lent Baysal</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>428</prism:startingPage> 
<prism:endingPage>432</prism:endingPage> 
<pubDate>2011-7-13</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0424.htm</link> 
<title>Placenta Percreta-Induced Uterine Rupture Diagnosed By Laparoscopy in the First Trimester</title> 
<description><![CDATA[ <p>Spontaneous uterine rupture is lethal in pregnant women. Placenta percreta-induced spontaneous uterine rupture in the first trimester is extremely rare and difficult to diagnose. A 35-year-old pregnant woman, with a history of 2 vaginal deliveries and 2 spontaneous abortions treated by dilatation and curettage, was admitted to the emergency department because of sudden severe abdominal pain; the gestational age as calculated by sonography was 14 weeks. Diagnostic laparoscopy was considered for surgical abdomen and fluid collection that was noted in sonography. During laparoscopy, uterine rupture with massive bleeding was detected; therefore, total abdominal hysterectomy was performed. The patient was discharged without any complications. Pathological analysis of the uterine specimen revealed placenta percreta to be the cause of the rupture. Uterine rupture should be considered in the differential diagnosis in all pregnant women who present with acute abdomen, show fluid collection in the peritoneal cavity. In addition, we recommend laparoscopy for the investigation of acute abdomen with unclear diagnosis in the first trimester of pregnancy.</p> ]]></description>  
<dc:creator>Dong Gyu Jang, Gui Se Ra Lee, Joo Hee Yoon, Sung Jong Lee</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>424</prism:startingPage> 
<prism:endingPage>427</prism:endingPage> 
<pubDate>2011-7-8</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0420.htm</link> 
<title>Spinal Intramedullary Cysticercosis: A Case Report and Literature Review</title> 
<description><![CDATA[ <p>Neurocysticercosis, involvement of the central nervous system by taenia solium, is one of the most common parasitic diseases of the CNS. However, spinal involvement by neurocysticercosis is uncommon. Here, we reported a 40-year-old woman with intramedullary cysticercosis in the thoracic spinal cord. MRI revealed two well-defined round intramedullary lesions at T4 and T5 vertebral levels, which were homogeneously hypointense on T1WI and hyperintense on T2WI with peripheral edema. Since the patient had progressive neurological deficits, surgery was performed to decompress the spinal cord. Histopathology examination of the removed lesion proved it was intramedullary cysticercosis. In this report, we also discussed the principles of diagnosis and treatment of intramedullary cysticercosis in combination of literature review.</p> ]]></description>  
<dc:creator>Bin Qi, Pengfei Ge, Hongfa Yang, Chunhua Bi, Yiping Li</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>420</prism:startingPage> 
<prism:endingPage>423</prism:endingPage> 
<pubDate>2011-7-6</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0413.htm</link> 
<title>Treat Ankylosing Spondylitis with Methazolamide</title> 
<description><![CDATA[ <p><b>Background:</b> Increased bone resorption and new bone information are two characteristics of ankylosing spondylitis (AS). Much evidence has shown that carbonic anhydrase inhibitors can restrain bone resorption. We had detected increased expression of carbonic anhydrase I (CA1) in synovium of patients with AS. This study aimed to evaluate the effectiveness and safety of methazolamide, an anti-carbonic anhydrase drug, for treating patients with AS.</p><p><b>Methods:</b> Two patients, called as S and L, were diagnosed with active AS based on BASDAI and BASFI assessments, radiographic data and other clinical indices. They took methazolamide tablets at a dose of 25 mg twice every day.</p><p><b>Results</b>: Patient S's BASDAI score fell from 5.4 to 4.4, while patient L's BASDAI fell from 2.4 to 2. Patient S's BASFI score change from 2.7 to 2.9, while patient L's BASFI score fell from 1.2 to 0.2. The ESR values of patient S were considerably reduced, while the ESR value of patient L remained unchanged and in the normal range. The calcium concentration of patient S decreased from 3.05 mmol/L to 2.39 mmol/L. The CT evidence indicates that the articular surfaces of the erosive sacroiliac joints became clearer and the area of the calcium deposits began decreased. No significant systemic side effects were observed in either patient.</p><p><b>Conclusions:</b> The above results indicate that methazolamide was effective for active AS. Methazolamide may improve AS symptoms by inhibiting carbonic anhydrase activity during the processes of bone reporption and new bone formation.</p> ]]></description>  
<dc:creator>Xiaotian Chang, Xinfeng Yan, Yunzhong Zhang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>413</prism:startingPage> 
<prism:endingPage>419</prism:endingPage> 
<pubDate>2011-7-1</pubDate>
<category>Short Research Communication</category>
</item>

<item>
<link>http://www.medsci.org/v08p0406.htm</link> 
<title>Effects of Bolus Injection of 5-Fluorouracil on Steady-State Plasma Concentrations of 5-Fluorouracil in Japanese Patients with Advanced Colorectal Cancer</title> 
<description><![CDATA[ <p><b>Objectives:</b> The irinotecan (CPT-11) + 5-fluorouracil (5-FU)/leucovorin (LV) + UFT/LV chemotherapy, in which repetitive oral administration of UFT/LV replaces the infusion of 5-FU/LV in the FOLFIRI regimen, has been proposed previously. In this study, five of 10 patients were injected with a bolus of 5-FU and the other were not injected with it in order to examine the effect of omitting it in terms of pharmacokinetics of 5-FU.</p><p><b>Methods:</b> The treatment consisted of the intravenous infusions of CPT-11 at 100 mg/m<sup>2 </sup>and <i>l</i>-LV at 15 mg/m<sup>2</sup>, and the injection of a bolus of 5-FU at 500 mg/m<sup>2</sup> on day 1, and the repetitive oral administration of UFT/LV (300 mg/m<sup>2</sup>/day as tegafur + 75 mg/day of LV) on days 1-5. A total of 13 measurements of the plasma concentrations of uracil, 5-FU and tegafur were made per patient within 48 hr after the start of chemotherapy and the value of area under the concentration-time curve (AUC<sub>0-48</sub>) was evaluated. The plasma concentration was also determined at 2 weeks to assess long-term exposure to 5-FU.</p><p><b>Results:</b> The plasma concentrations of 5-FU at 24 hr after the start of treatment were 27.4 ng/mL and 9.4 ng/mL in the patients with and without the bolus injection, respectively. At 48 hr, they were 31.3 ng/mL and 10.4 ng/mL with the AUC<sub>0-48</sub> values of 22.16 mg*h/L and 0.65 mg*h/L, respectively. The 5-FU was detected in the plasma at 226 hr after the last administration of UFT/LV for the patients with the bolus injection, but not for those without.</p><p><b>Conclusion:</b> A bolus of 5-FU on day 1 provided long-term exposure to 5-FU.</p> ]]></description>  
<dc:creator>Takao Tamura, Akiko Kuwahara, Kaori Kadoyama, Motohiro Yamamori, Kohshi Nishiguchi, Tsubasa Inokuma, Yoshiji Takemoto, Naoko Chayahara, Tatsuya Okuno, Ikuya Miki, Yoshimi Fujishima, Toshiyuki Sakaeda</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>406</prism:startingPage> 
<prism:endingPage>412</prism:endingPage> 
<pubDate>2011-7-1</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0402.htm</link> 
<title>Mirror-Image Arachnoid Cysts in a Pair of Monozygotic Twins: A Case Report and Review of the Literature</title> 
<description><![CDATA[ <p>Mirror-imaging of arachnoid cysts (ACs) in monozygotic twins (MZ) is extremely rare. We describe a pair of MZ who developed mirror-imaging of ACs in the temporal fossas, and we also review the literature. Brain computer tomography (CT) and Magnetic Resonance Imaging (MRI) of the MZ revealed mirror-imaging of vast lesions of cerebrospinal fluid intensity in their temporal fossas. This is the second ever report of such a case according to the available literature. Unlike the prior case, our patients were 14 months, which is a much younger age than the patients of the previous report. Consequently, our case is better in supporting a genetic origin in the pathogenesis of AC. The findings in our case indicate that early neuroimaging is mandatory in the counterpart of the symptomatic patient with AC, irrespective of the absence of symptoms.</p> ]]></description>  
<dc:creator>Jing-Yi Zhou, Jia-Li Pu, Sheng Chen, Yuan Hong, Chen-Han Ling, Jian-Min Zhang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>402</prism:startingPage> 
<prism:endingPage>405</prism:endingPage> 
<pubDate>2011-6-22</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0397.htm</link> 
<title>Communication Skills Training For Emergency Nurses</title> 
<description><![CDATA[ <p><b>Objective: </b>To determine the effects of a communication skills training program on emergency nurses and patient satisfaction.</p><p><b>Methods: </b>Sixteen emergency nurses attended a 6-week psychoeducation program that was intended to improve their communication skills. The first 3 sessions of the psychoeducation program consisted of theoretical education on empathy and communication. Other sessions covered awareness, active communication, and empathic skills on a cognitive behavioral basis using discussion, role play, and homework within an interactive group. The effects of the program were assessed using a communication skills scale, empathy scale, and patient satisfaction survey and were reflected by the reduction in the number of undesirable events between nurses and patients in the emergency department.</p><p><b>Results: </b>The mean communication skill score (177.8&#177;20) increased to 198.8&#177;15 after training (p=0.001). Empathy score also increased from 25.7&#177;7 to 32.6&#177;6 (p=0.001). The patient satisfaction survey of 429 patients demonstrated increased scores on confidence in the nurses (76.4&#177;11.2 to 84.6&#177;8.3; p=0.01); the nurse's respect, kindness, and thoughtfulness (72.2&#177; 8.1 to 82.1 &#177; 6,5; p=0.01); individualized attention (71.3&#177; 6.2 to 73.2 &#177; 9.8; p=0.2); devotion of adequate time to listening (84.6&#177; 9.3 to 89.8 &#177; 7.6; p=0.03); and counseling and information delivery (71.1&#177; 10.2 to 80.2 &#177; 9.7; p=0.01). The number of undesirable events and complaints during nurse-patient interactions decreased 66 % from 6 to 2.</p><p><b>Conclusion: </b>&#8220;Communication Skills Training&#8221; can improve emergency nurses' communication and empathy skills with a corresponding increase in patient satisfaction and reduction of the undesirable events and complaints during nurse-patient interactions.</p> ]]></description>  
<dc:creator>Mehmet Ak, Orhan Cinar, Levent Sutcigil, Emel Dovyap Congologlu, Bikem Haciomeroglu, Hayri Canbaz, Hulya Yaprak, Loni Jay, Kamil Nahit Ozmenler</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>397</prism:startingPage> 
<prism:endingPage>401</prism:endingPage> 
<pubDate>2011-6-22</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0387.htm</link> 
<title>Enhancement of the Click Chemistry for the Inverse Diels Alder Technology by Functionalization of Amide-Based Monomers</title> 
<description><![CDATA[ <p>In the near future personalized medicine with nucleic acids will play a key role in molecular diagnostics and therapy, which require new properties of the nucleic acids, like stability against enzymatic degradation. Here we demonstrate that the replacement of nucleobases with PNA by functional molecules harbouring either a dienophile or a diene reactivity is feasible and confers all new options for functionalization. These newly developed derivatives allow independent multi-ligations of multi-faceted components by use of the inverse Diels Alder technology. The high chemical stability and the ease of synthesis qualify these polyamide building blocks as favourites for intracellular delivery and targeting applications. This allows local drug concentrations sufficient for imaging and therapy and simultaneously a reduction of the application doses. It is important to point out that this technology is not restricted to ligation of medicament material; it is also a candidate to develop new and highly efficient active compounds for a &#8220;sustainable pharmacy&#8221;.</p> ]]></description>  
<dc:creator>Ruediger Pipkorn, Manfred Wiessler, Waldemar Waldeck, Peter Lorenz, Ute Muehlhausen, Heinz Fleischhacker, Mario Koch, Klaus Braun</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>387</prism:startingPage> 
<prism:endingPage>396</prism:endingPage> 
<pubDate>2011-6-21</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0380.htm</link> 
<title>Prevention of Pleural Adhesions Using a Membrane Containing Polyethylene Glycol in Rats</title> 
<description><![CDATA[ <p><b>Background:</b> Recurrent thoracotomies regardless of the cause are not a rare occurrence. However, each thoracotomy results in adhesion to some extent. This adhesions increase morbidity and mortality presents a significant inconvenience for surgeons and prolongs the length of operations.</p><p><b>Objective: </b>We investigated the efficacy of Prevadh&#174;, an anti-adhesion agent to prevent intrapleural adesions following thoracotomy in a rat model.</p><p><b>Methods:</b> Twenty male adult Wistar Albino rats were divided into a sham group (Group A, <i>n</i> = 4), a control group (Group B, <i>n</i> = 8), and a study group (Group C, <i>n</i> = 8). Only left thoracotomy was performed in Group A. Group B underwent left thoracotomy, induction of adhesion, and 1 ml saline solution was administered to the thoracic cavity. However, in Group C underwent left thoracotomy, induction of adhesion, and Prevadh&#174; was placed between the pleura and the lung. The rats were sacrificed on day 21, and adhesions were analyzed using both macroscopic and histopathological methods. The results were statistically analyzed. A value of <i>P</i>&#60;0.05 was considered statistically significant.</p><p><b>Results: </b>Mean lengths of adhesion differed statistically significantly among all three groups, while mean intensity of adhesion differed between Group A and Group B, and between Group B and Group C (<i>P</i>&#62;0.05). There was also a statistically significant difference between Group A and Group C in mesothelium proliferation score (<i>P</i>&#62;0.05). No statistically significant differences were found among the groups in terms of pleural thickness, macrophage and mononuclear cell infiltration (<i>P</i>&#62;0.05).</p><p><b>Conclusions: </b>Prevadh&#174; was shown in a rat model to effectively prevent post-thoracotomy adhesions.</p> ]]></description>  
<dc:creator>Volkan Karacam, Ahmet Onen, Aydin Sanli, Duygu Gurel, Aydanur Kargi, Sami Karapolat, Nezih Ozdemir</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>380</prism:startingPage> 
<prism:endingPage>386</prism:endingPage> 
<pubDate>2011-6-17</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0377.htm</link> 
<title>Surgical Treatment of Depressed Scar: A Simple Technique</title> 
<description><![CDATA[ <p>Scar formation is a process consequent to the healing of soft tissues after a trauma. However, abnormal or disturbed collagen production can cause anomalies of the cutaneous surface and textural irregularities. In the presence of a depressed scar in deep tissue, we began to use a new simple technique. In the presence of adherent scars, a small incision is performed so that an undermining scissor can enter inside. The entire cicatricial area is undermined on a subcutaneous plane which, by separating the deep scar from the superficial one, completely frees it from the present adhesions so that the existing depression is totally eliminated<i>.</i> In order to avoid the recreation of relapses, stitches formed in a U-shape are made in Nylon or Monocril 2-3/0 are made with a large needle and are placed close together so that a wide aversion is achieved at the margins of the scar and a deep wound closure is obtained by adhering to the undermined tissue. These stitches will then be removed about 2 weeks later.</p> ]]></description>  
<dc:creator>Francesco Inchingolo, Marco Tatullo, Fabio M. Abenavoli, Massimo Marrelli, Alessio D. Inchingolo, Roberto Corelli, Angelo M. Inchingolo, Gianna Dipalma</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>377</prism:startingPage> 
<prism:endingPage>379</prism:endingPage> 
<pubDate>2011-6-18</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0369.htm</link> 
<title>The Association Among Lipoprotein-associated Phospholipase A2 Levels, Total Antioxidant Capacity and Arousal in Male Patients with OSA</title> 
<description><![CDATA[ <p><b>Background: </b>The mechanisms of the increased cardiac and vascular events in patients with OSA are not well understood. Arousal which is an important component of OSA was associated with increased sympathetic activation and electrocardiographic changes which prone to arrhythmias. We planned to examine the association among arousal, circulating Lp-PLA2 and total antioxidant capacity in male patients with OSA.</p><p><b>Methods:</b> Fifty male patients with newly diagnosed OSA were enrolled the study. A full-night polysomnography was performed and arousal index was obtained. Lp-PLA2 concentrations were measured in serum samples with the PLAC Test. Total antioxidant capacity in patients was determined with Antioxidant Assay Kit.</p><p><b>Results: </b>Arousal was positively correlated with LP-PLA2 levels (r=0.43, p=0.002) and was negatively correlated with total antioxidant capacity (r= -0.29, p=0.04). Elevated LP-PLA2 levels and decreased total antioxidant activities were found in the highest arousal quartile compared with the lowest and 2nd quartiles (p=0.02, p=0.05, respectively). LP-PLA2 was an independently predictor of arousal index in regression model (&#946;=0.357, p=0.002)</p><p><b>Conclusions: </b>This study demonstrated a moderate linear relationship between arousal and LP-PLA2 levels. Also, total antioxidant capacities were decreased in the higher arousal index. Based on the study result, the patients with higher arousal index may be prone to vascular events.</p> ]]></description>  
<dc:creator>Taha T. Bekci, Mehmet Kayrak, Aysel Kiyici, Emin Maden, Hatem Ari, Zeynettin Kaya, Turgut Teke, Hakan Akilli</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>369</prism:startingPage> 
<prism:endingPage>376</prism:endingPage> 
<pubDate>2011-6-10</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0362.htm</link> 
<title>The Versatile Use of Temporoparietal Fascial Flap</title> 
<description><![CDATA[ <p><b>Background:</b> The pedicled or free temporoparietal fascial has been used in many areas, especially in head and neck reconstruction. This thin, pliable, highly vascularized flap may be also transferred as a carrier of subjacent bone or overlying skin.</p><p><b>Objective:</b> The aim of this study is to report our experience in versatile use of temporoparietal fascial flap (TPFF) and discuss the surgical anatomy and technique.</p><p><b>Patients and Methods: </b>A total number of 57 TPFFs have been used in periorbital, mid-facial, auricular, and tracheal reconstruction due to tumor resection, trauma, and congenital ear deformities.</p><p><b>Results:</b> All the flaps were successfully transferred without any major complication. The cosmetic results were quite satisfactory to all patients.</p><p><b>Conclusion:</b> The advantages and minimal donor site morbidity of TPPF makes this flap a good choice in many reconstructive procedures.</p> ]]></description>  
<dc:creator>Cenk Demirdover, Baris Sahin, Haluk Vayvada, Hasan Yucel Oztan</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>362</prism:startingPage> 
<prism:endingPage>368</prism:endingPage> 
<pubDate>2011-6-10</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0353.htm</link> 
<title>Emulsified Isoflurane Preconditioning Reduces Lung Injury Induced By Hepatic Ischemia/Reperfusion in Rats</title> 
<description><![CDATA[ <p><i>Objective: </i>To investigate whether emulsified isoflurane preconditioning could reduce lung injury induced by hepatic I/R in rats and its mechanism.</p><p><i>Materials and methods: </i>32 pentobarbital-anesthetized Sprague-Dawley rats were equally randomized into four groups: laparotomy group (Sham group), hepatic I/R and normal saline infusion group (I/R+S group), I/R and lipid vehicle infusion (I/R+V group), or I/R and 8% emulsified isoflurane infusion (I/R+E group) at the rate of 8 ml&#183;kg<sup>-1</sup>&#183;h<sup>-1</sup> for 30 min. Blood supply of the hepatic artery and portal vein to the left and the median liver lobes was occluded for 90 min after 30-min washout time. Reperfusion was allowed to proceed for 4 h before sacrifice of the animals. Lung injury was observed histologically. Neutrophil infiltration and TNF-&#945; concentration in serum and lung were measured. Changes of wet-to-dry weight ratios in lung tissue, ICAM-1 expression and NF-&#954;B activity in lung after hepatic I/R were determined.</p><p><i>Results: </i>Compared with I/R+S or I/R+V group, emulsified isoflurane preconditioning reduced hepatic I/R-induced lung histologic injury and inhibited the increase of myeloperoxidase (MPO) activity in the lung tissue markedly (5.5&#177;1.37 and 5.22&#177;1.33 <i>vs</i> 3.81&#177;1.62 U/g, P&#60;0.05). In addition, both serum and lung tissue TNF-&#945; levels were reduced in I/R+E group (104.58&#177;31.40 and 94.60&#177;22.23 <i>vs</i> 72.44&#177;17.28 pg/ml, P&#60;0.05; 393.51&#177;88.22 and 405.46&#177;102.87 <i>vs</i> 292.62&#177;74.56 pg/ml, P&#60;0.01). Emulsified isoflurane preconditioning also inhibited the increase of ICAM-1 expression (0.79&#177;0.17 and 0.84&#177;0.24 <i>vs</i> 0.62&#177;0.21, P&#60;0.05) and NF-&#954;B translocation (4.93&#177;0.48 and 4.76&#177;0.57 <i>vs</i> 4.01&#177;0.86, P&#60;0.05) in the lung tissue markedly.</p><p><i>Conclusions: </i>Emulsified isoflurane preconditioning markedly attenuated hepatic I/R-induced lung injury in rats, which may be hopefully applied to the clinical treatment of organ injury caused by hepatic surgery, transplantation or hemorrhagic shock.</p> ]]></description>  
<dc:creator>Xin Lv, Zhen-meng Wang, Sheng-dong Huang, Shao-hua Song, Fei-xiang Wu, Wei-feng Yu</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>5</prism:number> 
<prism:startingPage>353</prism:startingPage> 
<prism:endingPage>361</prism:endingPage> 
<pubDate>2011-6-8</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0351.htm</link> 
<title>Medical Decision and Patient's Preference: 'Much Ethics' and More Trust Always Needed</title> 
<description><![CDATA[ <p>There is much discussion on medical ethics literature regarding the importance of the patients' right for self-determination. We discuss some of the limitations of patient's autonomy with the aim to draw attention to the ethical complexity of medical decision making in the everyday clinical practice.</p> ]]></description>  
<dc:creator>Dimitrios Anyfantakis, Emmanouil K Symvoulakis</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>351</prism:startingPage> 
<prism:endingPage>352</prism:endingPage> 
<pubDate>2011-5-31</pubDate>
<category>Letter</category>
</item>

<item>
<link>http://www.medsci.org/v08p0345.htm</link> 
<title>Foramen Magnum Arachnoid Cyst Induces Compression of the Spinal Cord and Syringomyelia: Case Report and Literature Review</title> 
<description><![CDATA[ <p>It is very rare that a foramen magnum arachnoid cyst induces compression of the spinal cord and syringomyelia, and currently there are few treatment experiences available. Here we reported the case of a 43-year-old male patient who admitted to the hospital due to weakness and numbness of all 4 limbs, with difficulty in urination and bowel movement. MRI revealed a foramen magnum arachnoid cyst with associated syringomyelia. Posterior fossa decompression and arachnoid cyst excision were performed. Decompression was fully undertaken during surgery; however, only the posterior wall of the arachnoid cyst was excised, because it was almost impossible to remove the whole arachnoid cyst due to toughness of the cyst and tight adhesion to the spinal cord. Three months after the surgery, MRI showed a reduction in the size of the arachnoid cyst but syrinx still remained. Despite this, the symptoms of the patient were obviously improved compared to before surgery. Thus, for the treatment of foramen magnum arachnoid cyst with compression of the spinal cord and syringomyelia, if the arachnoid cyst could not be completely excised, excision should be performed as much as possible with complete decompression of the posterior fossa, which could result in a satisfying outcome.</p> ]]></description>  
<dc:creator>Haiyan Huang, Yuanqian Li, Kan Xu, Ye Li, Limei Qu, Jinlu Yu</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>345</prism:startingPage> 
<prism:endingPage>350</prism:endingPage> 
<pubDate>2011-5-27</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0339.htm</link> 
<title>The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey</title> 
<description><![CDATA[ <p><b>Purpose:</b> Antimicrobial resistance among microorganisms is a global concern. In 2003, a nationwide antibiotic restriction program (NARP) was released in Turkey. In this study we evaluated the effect of NARP on antibiotic consumption, antimicrobial resistance, and cost.</p><p><b>Materials and Methods:</b> The data obtained from all of the four university hospitals, and one referral tertiary-care educational state hospital in Ankara. Antimicrobial resistance profiles of 14,233 selected microorganisms all grown in blood cultures and antibiotic consumption from 2001 to 2005 were analyzed retrospectively.</p><p><b>Results</b>: A negative correlation was observed between the ceftriaxone consumption and the prevalence of ceftriaxone resistant <i>E.coli </i>and <i>Klebsiella </i>spp<i>.</i> (rho:-0.395, <i>p</i>:0.332 and rho:-0.627,<i> p</i>:0.037, respectively). The decreased usage of carbapenems was correlated with decreased carbapenems-resistant <i>Pseudomonas</i> spp<i>.</i> and <i>Acinetobacter </i>spp (rho:0.155,<i> p</i>:0.712 and rho:0.180, <i>p</i>:0.668, respectively for imipenem). Methicillin resistance rates of <i>S.aureus</i> were decreased from 44% to 41%. After two years of NARP 5,389,155.82 USD saving occurred.</p><p><b>Conclusion:</b> NARP is effective in lowering the costs and antibiotic resistance.</p> ]]></description>  
<dc:creator>Adalet Altunsoy, Cenk Aypak, Alpay Azap, &#214;nder Erg&#246;n&#252;l, &#304;smail Bal&#305;k</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>339</prism:startingPage> 
<prism:endingPage>344</prism:endingPage> 
<pubDate>2011-5-24</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0332.htm</link> 
<title>Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS</title> 
<description><![CDATA[ <p><b>Objective:</b> Adverse event reports (AERs) submitted to the US Food and Drug Administration (FDA) were reviewed to confirm the platinum agent-associated mild, severe, and lethal hypersensitivity reactions.</p><p><b>Methods:</b> Authorized pharmacovigilance tools were used for quantitative signal detection, including the proportional reporting ratio, the reporting odds ratio, the information component given by a Bayesian confidence propagation neural network, and the empirical Bayes geometric mean. Excess2, given by the multi-item gamma Poisson Shrinker algorithm, was used to evaluate the effects of dexamethasone and diphenhydramine on oxaliplatin-induced hypersensitivity reactions.</p><p><b>Results:</b> Based on 1,644,220 AERs from 2004 to 2009, carboplatin and oxaliplatin proved to cause mild, severe, and lethal hypersensitivity reactions, whereas cisplatin did not. Dexamethasone affected oxaliplatin-induced mild hypersensitivity reactions, but had lesser effects on severe and lethal reactions. The effects of diphenhydramine were not confirmed.</p><p><b>Conclusion:</b> The FDA's adverse event reporting system, AERS, with optimized data mining tools is useful to authorize potential associations between platinum agents and hypersensitivity reactions.</p> ]]></description>  
<dc:creator>Toshiyuki Sakaeda, Kaori Kadoyama, Hiroaki Yabuuchi, Satoshi Niijima, Kyoko Seki, Yukinari Shiraishi, Yasushi Okuno</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>332</prism:startingPage> 
<prism:endingPage>338</prism:endingPage> 
<pubDate>2011-5-21</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0321.htm</link> 
<title>Seroprevalence and Risk Factors for Hepatitis B Infection in an Adult Population in Northeast China</title> 
<description><![CDATA[ <p><b>Background and aim: </b>The prevalence of the hepatitis B virus (HBV) is higher in adults than in children. We determined the seroepidemiology of HBV infection in an adult population in JiLin, China, to guide effective preventive measures.</p><p><b>Methods:</b> A cross-sectional serosurvey was conducted throughout JiLin, China. A total of 3833 people was selected and demographic and behavioral information gathered. Serum samples were tested for HBV markers and liver enzymes.</p><p><b>Results: </b>The prevalence of the hepatitis B surface antigen (HBsAg), the antibody to the hepatitis B surface antigen (anti-HBs), the hepatitis B e antigen (HBeAg), the antibody to HBeAg (anti-HBe), and the antibody to the hepatitis B core antigen (anti-HBc) were 4.38%, 35.66%, 1.38%, 6.65%, and 40.88%, respectively. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were significantly higher among HBsAg (+) than HBsAg (-) subjects. By multivariate logistic regression analysis, independent predictors for chronic HBV infection were smoking, poor sleep quality; occupation as private small-businessmen, laborers, or peasants; male gender; family history of HBV; personal history of vaccination; and older age. Independent predictors for exposure to HBV were large family size, occupation as a private small-businessman, male gender, family history of HBV, personal history of vaccination, and older age. Independent predictors for immunity by vaccination were occupation as a private small-businessman, high income, personal history of vaccination, and young age. Independent predictors for immunity by exposure were drinking, male gender, personal history of vaccination, and older age.</p><p><b>Conclusions: </b>The prevalence rate of HBV infection (4.38%) was lower than the previous rate of general HBV vaccination. However, 44.59% of the population remained susceptible to HBV. The prevalence of HBV infection was high in young adults, private small-businessmen, peasants, those with a family history of HBV, and males. Therefore, immunization of the non-immune population is reasonable to reduce hepatitis B transmission between adults.</p> ]]></description>  
<dc:creator>Hong Zhang, Qingmei Li, Jie Sun, Chunyan Wang, Qing Gu, Xiangwei Feng, Bing Du, Wei Wang, Xiaodong Shi, Siqi Zhang, Wanyu Li, Yanfang Jiang, Junyan Feng, Shumei He, Junqi Niu</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>321</prism:startingPage> 
<prism:endingPage>331</prism:endingPage> 
<pubDate>2011-5-20</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0315.htm</link> 
<title>Can Occult Cystobiliary Fistulas in Hepatic Hydatid Disease Be Predicted Before Surgery?</title> 
<description><![CDATA[ <p><b>Background:</b> Biliary fistulas because of the cystobiliary communication is the most frequent and undesirable postoperative complication of hepatic hydatid surgery. We aimed to identify the predicting factors of the occult cystobiliary communication in this study.</p><p><b>Methods</b>: The patients who underwent surgical treatment for hepatic hydatid disease between 2003 and 2008 were reviewed retrospectively. The patients who had jaundice history, preoperative high total bilirubin and direct bilirubin levels, dilated bile duct in preoperative radiologic imagings were not included the study. Patients were divided into two groups: group A; without postoperative biliary fistula, group B; with biliary fistula. The two groups were compared according to preoperative descriptive findings, cystic specialties, and laboratory findings.</p><p><b>Results:</b> There were 53 patients and 15 patients in groupA and groupB, respectively. The 20 (37.7%) of 53 patients were male in group A and the 10 (66.7%) patients were male in group B (p&#60;0.05). The age, number of cysts, Garbi scores of cysts, the rate of recurrent cysts, the level of preoperative bilirubine, alkalene phosphatase, and transaminases were similar in both groups (p&#62;0.05). GGT was significantly different between two groups (p&#60;0.05). The cystotomy + drainage, cystotomy + omentopexy, and intracystic biliary suture rates were similar in both groups. Postoperative non biliary complications were determined in 4 (7.5%) patients in group A and 7 patients (46.7%) in group B (p&#60;0.05). Hospital stay was longer in group B significantly (p&#60;0.05).</p><p><b>Conclusions: </b>In conclusion, GGT as a labaratory test for predicting occult CBC preoperatively have been shown to be useful in the clinical practice. However, larger prospective studies are needed on this subject. Occult cysto-biliary fistulas can only be exposed during surgery when suspected by a surgeon. If occult CBC is found, the opening in the biliary system should be sutured with absorbable material, with or without cystic duct drainage. If no biliary opening is found, cystic duct drainage may be performed if preoperative factors predict the presence of CBC. As the development of external biliary fistulas increases the morbidity and the hospitalization period, novel surgical methods to prevent the development of bile fistulas are required in such patients.</p> ]]></description>  
<dc:creator>Kemal Atahan, Hakan K&#252;peli, Mehmet Deniz, Serhat G&#252;r, Atilla &#199;&#246;kmez, Erc&#252;ment Tarcan</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>315</prism:startingPage> 
<prism:endingPage>320</prism:endingPage> 
<pubDate>2011-5-19</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0309.htm</link> 
<title>Monoclonal Antibodies against Nucleophosmin Mutants: Potentials for the Detection of Acute Myeloid Leukemia</title> 
<description><![CDATA[ <p>Nucleophosmin (<i>NPM1</i>) gene mutations resulting in cytoplasmic delocalization of Nucleophosmin (NPMc+) are the most common genetic alteration in acute myeloid leukemia (AML). Here, we attempted to prepare monoclonal antibodies (mAbs) against <i>NPM1 </i>mutation A (NPM-mA) and investigated the mAbs' clinical utility in immunohistochemical detection of NPMc+AML. The pET-32a-NPM-mA vector with the whole open reading frame of the NPM-mA gene was constructed.<i> E.coli</i> BL21 transformed with the vector were induced to express the NPM-mA recombinant protein. BALB/c mice were immunized with the recombinant NPM-mA. Positive clones were selected by indirect ELISA and the mAbs were obtained. Immunohistochemistry was performed to detect the NPMc+ in bone marrow smears from 10 AML patients with NPM-mA. The results showed that the pET-32a-NPM-mA vector was successfully constructed and the NPM-mA recombinant protein was used to immunize the mice. Two positive clones (2G3 and 3F9) were selected. The mAbs against NPM-mA were raised, but did cross-react with wild type NPM1. The mAbs can be used to detect the cytoplasmic dislocation of NPM1 in all AMLs carrying NPM-mA. Our results show that anti-NPM-mA mAbs were produced. Though they would cross-react with wild type NPM1, the mAbs may still have potential in the detection of NPMc+AMLs.</p> ]]></description>  
<dc:creator>Shi Tan, Ling Zhang, Xiao-Ming Zhong, Zai-Lin Yang, Liu-Yang Zhao, Yu-Jie Gao, Hui-Yuan Shao, Feng-Xian Qin, Xian-Chun Chen, Hui-Juan Zhang, Hui Chen, Li Wang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>309</prism:startingPage> 
<prism:endingPage>314</prism:endingPage> 
<pubDate>2011-5-17</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0302.htm</link> 
<title>Soluble Endothelial Selectin in Acute Lung Injury Complicated by Severe Pneumonia</title> 
<description><![CDATA[ <p><b>Background: </b>Pneumonia is still one of the most frequent causes of death in the elderly. Complication of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) by pneumonia makes patients very ill due to severe respiratory failure. Biomarkers that can discriminate the presence of complicating ALI/ARDS are required for early detection. The aim of this research was to investigate whether soluble endothelial selectin (sES) could be a biomarker for ALI.</p><p><b>Methods: </b>Serum sES levels were measured in 27 pneumonia patients, who were enrolled between April 2006 and September 2007. Among these patients, six had ALI or a condition that was clinically comparable to ALI (cALI). All patients who were enrolled were successfully treated and survived.</p><p><b>Results: </b>Circulating sES levels were elevated in pneumonia patients with ALI/cALI, and sES levels decreased following treatment of their pneumonia. Univariate and multivariate logistic regression analyses showed that sES was the only significant factor for identifying complicating ALI/cALI, independently of C-reactive protein (CRP) and lactate dehydrogenase (LDH). By receiver operating characteristic (ROC) curve analysis, the cut-off value for sES was 40.1 ng/mL, with a sensitivity of 0.8 and a specificity of 0.8.</p><p><b>Conclusion: </b>sES may be a useful biomarker for discriminating complicating ALI/cALI in patients with severe pneumonia.</p> ]]></description>  
<dc:creator>Daisuke Osaka, Yoko Shibata, Kazunori Kanouchi, Michiko Nishiwaki, Tomomi Kimura, Hiroyuki Kishi, Shuichi Abe, Sumito Inoue, Yoshikane Tokairin, Akira Igarashi, Keiko Yamauchi, Yasuko Aida, Takako Nemoto, Keiko Nunomiya, Koji Fukuzaki, Isao Kubota</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>302</prism:startingPage> 
<prism:endingPage>308</prism:endingPage> 
<pubDate>2011-5-11</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0295.htm</link> 
<title>Effects of p-Synephrine alone and in Combination with Selected Bioflavonoids on Resting Metabolism, Blood Pressure, Heart Rate and Self-Reported Mood Changes</title> 
<description><![CDATA[ <p>Bitter orange (<i>Citrus aurantium</i>) extract is widely used in dietary supplements for weight management and sports performance. Its primary protoalkaloid is <i>p</i>-synephrine. Most studies involving bitter orange extract and <i>p</i>-synephrine have used products with multiple ingredients. The current study assessed the thermogenic effects of <i>p</i>-synephrine alone and in conjunction with the flavonoids naringin and hesperidin in a double-blinded, randomized, placebo-controlled protocol with 10 subjects per treatment group. Resting metabolic rates (RMR), blood pressure, heart rates and a self-reported rating scale were determined at baseline and 75 min after oral ingestion of the test products in V-8 juice. A decrease of 30 kcal occurred in the placebo control relative to baseline. The group receiving <i>p</i>-synephrine (50 mg) alone exhibited a 65 kcal increase in RMR as compared to the placebo group. The consumption of 600 mg naringin with 50 mg <i>p</i>-synephrine resulted in a 129 kcal increase in RMR relative to the placebo group. In the group receiving 100 mg hesperidin in addition to the 50 mg <i>p</i>-synephrine plus 600 mg naringin, the RMR increased by 183 kcal, an increase that was statistically significant with respect to the placebo control (p&#60;0.02). However, consuming 1000 mg hesperidin with 50 mg <i>p</i>-synephrine plus 600 mg naringin resulted in a RMR that was only 79 kcal greater than the placebo group. None of the treatment groups exhibited changes in heart rate or blood pressure relative to the control group, nor there were no differences in self-reported ratings of 10 symptoms between the treatment groups and the control group. This unusual finding of a thermogenic combination of ingredients that elevated metabolic rates without corresponding elevations in blood pressure and heart-rates warrants longer term studies to assess its value as a weight control agent<b>.</b></p> ]]></description>  
<dc:creator>Sidney J. Stohs, Harry G Preuss, Samuel C. Keith, Patti L. Keith, Howard Miller, Gilbert R. Kaats</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>295</prism:startingPage> 
<prism:endingPage>301</prism:endingPage> 
<pubDate>2011-4-28</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0287.htm</link> 
<title>Knockdown of NPM1 by RNA Interference Inhibits Cells Proliferation and Induces Apoptosis in Leukemic Cell Line</title> 
<description><![CDATA[ <p>Nucleophosmin (NPM1) is an abundant and ubiquitously expressed phosphoprotein that is known to influence solid tumors progression. However, little is known about the role of NPM1 in leukemia. Here, we knocked down the <i>NPM1</i> expression by RNA interference to investigate the role of NPM1 in leukemic cells proliferation and apoptosis. The interference vector pNPM1-shRNA was constructed and transfected into the human leukemic K562 cell line. The expression levels of <i>NPM1</i> mRNA and protein were detected by quantitative real-time PCR and Western blot, respectively. Cells proliferation potential <i>in vitro</i> was assessed by methyl thiazolyl tetrazolium (MTT) and colony formation assays. Flow cytometry was used to detect the distribution of cell cycle. Cellular apoptosis was reflected by the relative activities of caspase-3 and caspase-8. The results showed that the expression levels of <i>NPM1</i> mRNA and protein in K562 cells were significantly reduced after pNPM1-shRNA transfection. The cells growth was significantly inhibited in a time-dependent manner and the number of colonies was significantly reduced in the pNPM1-shRNA transfected cells. Meanwhile, the percentage of cells in G1 phase in the K562/pNPM1-shRNA cells was significantly increased. In addition, there were higher relative activities of caspase-3/8 in the pNPM1-shRNA transfected cells. These results indicate that down-regulation of <i>NPM1</i> expression inhibits leukemic cells proliferation, blocks cell cycle progression and induces cellular apoptosis. It may implicate a potential target for leukemia gene therapy.</p> ]]></description>  
<dc:creator>Feng-Xian Qin, Hui-Yuan Shao, Xian-Chun Chen, Shi Tan, Hui-Juan Zhang, Zong-Yu Miao, Li Wang,  Hui-Chen, Ling Zhang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>287</prism:startingPage> 
<prism:endingPage>294</prism:endingPage> 
<pubDate>2011-4-20</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0283.htm</link> 
<title>Minimally Invasive Parathyroidectomy Using Surgical Sonography</title> 
<description><![CDATA[ <p>Minimally invasive parathyroidectomy is the procedure of choice for primary hyperparathyroidism due to parathyroid adenoma. Localization of the offending adenoma in minimally invasive parathyroidectomy (MIP) has been described in the literature aided by isotope, telescope or ultrasound guidance. We present a prospective study of two techniques based on surgeon experience. Thirty patients diagnosed with primary hyperparathyroidism at the Mater hospital in Dublin, Ireland were randomized to have a minimally invasive parathyroidectomy using surgical sonography (MIPUSS) or the conventional unilateral open procedure (OP) over a two year period. The age, sex and serum calcium/parathormone were comparable in both groups. There was no significant difference in complications between the two groups with temporary hypocalcemia occurring in 3 patients undergoing unilateral neck exploration and in 2 MIPUSS patients. There was one transient episode of recurrent laryngeal neuropraxia occurring in the OP group which resolved at 30 day follow-up. The incision size, operating time, hospital stay, and required post-operative analgesia were all markedly reduced in the MIPUSS group. In conclusion, MIPUSS is safe, effective and has advantages in terms of operating time, incision size and early discharge.</p> ]]></description>  
<dc:creator>Karim W Sadik, Malcolm Kell, Tom Gorey</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>4</prism:number> 
<prism:startingPage>283</prism:startingPage> 
<prism:endingPage>286</prism:endingPage> 
<pubDate>2011-4-15</pubDate>
<category>Short Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0278.htm</link> 
<title>Aplasia and Agenesis of the Frontal Sinus in Turkish Individuals: A Retrospective Study Using Dental Volumetric Tomography</title> 
<description><![CDATA[ <p>Agenesis of the paranasal sinuses is an uncommon clinical condition that appears mainly in the frontal (12%) and maxillary (5-6%) sinuses; in some populations, it appears at a higher proportion. This study investigated the prevalence of agenesis of the frontal sinuses using dental volumetric tomography (DVT) in Turkish individuals. The frontal sinuses of 410 patients were examined by DVT scans in the coronal planes for evidence of the absence of the frontal sinuses. A bilateral and unilateral absence of the frontal sinuses was seen in 0.73% and 1.22% of cases, respectively. In one case, both agenesis and aplasia of the frontal sinus was seen (0.24%). The low percentage of frontal sinus agenesis must be considered during pre-surgical planning related to the sinuses. DVT may be used as a diagnostic tool for the examination of frontal sinus aplasia.</p> ]]></description>  
<dc:creator>Binali &#199;akur, Muhammed A. Sumbullu, Nurhan Bay&#305;nd&#305;r Durna</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>278</prism:startingPage> 
<prism:endingPage>282</prism:endingPage> 
<pubDate>2011-4-8</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0270.htm</link> 
<title>2009 H1N1 Influenza and Experience in Three Critical Care Units</title> 
<description><![CDATA[ <p><b>Aim: </b>We describe futures of ICU admission, demographic characteristics, treatment and outcome for critically ill patients with laboratory-confirmed and suspected infection with the H1N1 virus admitted to the three different critical care departments in Turkey.</p><p><b>Methods:</b> Retrospective study of critically ill patients with 2009 influenza A(H1N1) at ICU. Demographic data, symptoms, comorbid conditions, and clinical outcomes were collected using a case report form.</p><p><b>Results:</b> Critical illness occurred in 61 patients admitted to an ICU with confirmed (n=45) or probable and suspected 2009 influenza A(H1N1). Patients were young (mean, 41.5 years), were female (54%). Fifty-six patients, required mechanical ventilation (14 invasive, 27 noninvasive, 15 both) during the course of ICU. On admission, mean APACHE II score was 18.7&#177;6.3 and median PaO<sub>2</sub>/FIO<sub>2</sub> was 127.9&#177;70.4. 31 patients (50.8%) was die. There were no significant differences in baseline PaO<sub>2</sub>/FIO<sub>2 </sub>and ventilation strategies between survivors and nonsurvivors. Patients who survived were more likely to have NIMV use at the time of admission to the ICU.</p><p><b>Conclusion:</b> Critical illness from 2009 influenza A(H1N1) in ICU predominantly affects young patients with little major comorbidity and had a high case-fatality rate. NIMV could be used in 2009 influenza A (H1N1) infection-related hypoxemic respiratory failure.</p> ]]></description>  
<dc:creator>Turgut Teke, Ramazan Coskun, Murat Sungur, Muhammed Guven, Taha T Bekci, Emin Maden, Emine Alp, Mehmet Doganay, Ibrahim Erayman, Kursat Uzun</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>270</prism:startingPage> 
<prism:endingPage>277</prism:endingPage> 
<pubDate>2011-4-7</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0263.htm</link> 
<title>Endovascular Treatment of Bilateral Carotid Artery Occlusion with Concurrent Basilar Apex Aneurysm: A Case Report and Literature Review</title> 
<description><![CDATA[ <p>We report a case of successful endovascular treatment of bilateral carotid artery occlusion with concurrent basilar apex aneurysm. An elderly female patient with subarachnoid hemorrhage (SAH) onset was admitted to the hospital. Computed tomography (CT) and digital subtraction angiography (DSA) confirmed the presence of bilateral carotid artery occlusion with concurrent basilar apex aneurysm. Brain blood supply was provided by the bilateral vertebral artery through the basilar artery. We treated the aneurysm with the endovascular approach by embolizing the aneurysm with three coils. The patient recovered well after surgery and showed no recanalization of the aneurysm on a one-year follow-up DSA. We also reviewed six similar cases found with a PUBMED database search (1980-2010), including those with bilateral common carotid artery occlusion. In conclusion, by using the endovascular approach, bilateral carotid artery occlusion with concurrent basilar apex aneurysm was efficiently treated.</p> ]]></description>  
<dc:creator>Kan Xu, Honglei Wang, Qi Luo, Ye Li, Jinlu Yu</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>263</prism:startingPage> 
<prism:endingPage>269</prism:endingPage> 
<pubDate>2011-3-30</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0254.htm</link> 
<title>Prevalence and Etiology of Abnormal Liver Tests in an Adult Population in Jilin, China</title> 
<description><![CDATA[ <p><b>Background: </b>Serum biochemical liver tests (LTs) (alanine aminotransferase, aspartate aminotransferase, and gamma glutamyltransferase) and platelet counts are often used to screen for chronic liver disease. We determined the prevalence and etiologies of abnormal LTs in an adult population in Jilin, China.</p><p><b>Methods:</b> A total of 3791 individuals between the ages of 18 and 79 years were interviewed and then underwent ultrasonography and blood tests.</p><p><b>Results:</b> The prevalence of abnormal LTs was 14.77% (560 out of 3791 subjects). The risk factors for abnormal LTs were non-alcoholic fatty liver disease (NAFLD) alone, which accounted for 11.61%, metabolic syndrome alone for 25%, or both for 22.14%. Abnormal LTs were more common in male than in female subjects. The development of abnormal LTs was correlated with older age males, increased daily alcohol intake, poor quality of sleep, smoking, fasting plasma glucose, body mass index, triglyceridemia, and low-density lipoprotein. Abnormal LTs in patients with metabolic syndrome and NAFLD were associated with high fasting plasma glucose, triglycerides, body mass index, low density lipoprotein, male, young age, poor sleep quality, smoking, and alcohol intake. However, abnormal LTs in patients with hepatitis B virus were associated with gender and increased age.</p><p><b>Conclusions:</b> The results from the current study demonstrated that the prevalence of abnormal LTs is high in the population (14.77%). Metabolic syndrome, NAFLD, and alcohol intake appear to be potentially important causes of the observed abnormal LTs.</p> ]]></description>  
<dc:creator>Hong Zhang, Shu Mei He, Jie Sun, ChunYan Wang, Yan Fang Jiang, Qing Gu, Xiang Wei Feng, Bing Du, Wei Wang, Xiao Dong Shi, Si Qi Zhang, Wan Yu Li, Jun Qi Niu</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>254</prism:startingPage> 
<prism:endingPage>262</prism:endingPage> 
<pubDate>2011-3-25</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0245.htm</link> 
<title>Current Status of Methods to Assess Cancer Drug Resistance</title> 
<description><![CDATA[ <p>Drug resistance is the main cause of the failure of chemotherapy of malignant tumors, resistance being either preexisting (intrinsic resistance) or induced by the drugs (acquired resistance). At present, resistance is usually diagnosed during treatment after a long period of drug administration.</p><p>In the present paper, methods for a rapid assessment of drug resistance are described. Three main classes of test procedures can be found in the literature, i.e. fresh tumor cell culture tests, cancer biomarker tests and positron emission tomography (PET) tests. The methods are based on the evaluation of molecular processes, i.e. metabolic activities of cancer cells. Drug resistance can be diagnosed before treatment in-vitro with fresh tumor cell culture tests, and after a short time of treatment in-vivo with PET tests. Cancer biomarker tests, for which great potential has been predicted, are largely still in the development stage. Individual resistance surveillance with tests delivering rapid results signifies progress in cancer therapy management, by providing the possibility to avoid drug therapies that are ineffective and only harmful.</p> ]]></description>  
<dc:creator>Theodor H. Lippert, Hans-J&#246;rg Ruoff, Manfred Volm</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>245</prism:startingPage> 
<prism:endingPage>253</prism:endingPage> 
<pubDate>2011-3-23</pubDate>
<category>Review</category>
</item>

<item>
<link>http://www.medsci.org/v08p0239.htm</link> 
<title>Long Term Persistence of IgE Anti-Influenza Virus Antibodies in Pediatric and Adult Serum Post Vaccination with Influenza Virus Vaccine</title> 
<description><![CDATA[ <p>The production of IgE specific to different viruses (HIV-1, Parvovirus B19, Parainfluenza virus, Varicella Zoster Virus), and the ability of IgE anti-HIV-1 to suppress HIV-1 production <i>in vitro</i>, strongly suggest an important role for IgE and/or anti viral specific IgE in viral pathogenesis. Nevertheless, the presence and persistence of IgE anti-Influenza virus antibodies has not been studied. Total serum IgE and specific IgE and IgG anti-Influenza virus antibodies were studied in children (N=3) (m/f 14-16 y/o) and adults (N=3) (m/f, 41-49 y/o) 2-20 months after vaccination with Influenza virus (Flumist<sup>&#174;</sup> or Fluzone<sup>&#174;</sup>), as well as in non-vaccinated children (N=2). (UniCAP total IgE Fluoroenzymeimmunoassay, ELISA, Immunoblot). We found that serum of vaccinated children and adults contained IgE and IgG anti-Influenza virus antibodies approaching two years post vaccination. Non-vaccinated children did not make either IgE or IgG anti-Influenza antibodies. Similar levels of IL-2, IFN-&#947;, IL-4, and IL-10 cytokines were detected in serum of vaccinated compared with non vaccinated subjects (p&#62;0.05), as well as between vaccinated adults compared with vaccinated children and non vaccinated subjects (p&#62;0.05). Vaccinated children and adults continue to produce IgE anti-Influenza virus antibodies long term post vaccination. The long term production of IgE anti-Influenza virus antibodies induced by vaccination may contribute to protective immunity against Influenza.</p> ]]></description>  
<dc:creator>Tamar A. Smith-Norowitz, Darrin Wong, Melanie Kusonruksa, Kevin B. Norowitz, Rauno Joks, Helen G. Durkin, Martin H. Bluth</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>239</prism:startingPage> 
<prism:endingPage>244</prism:endingPage> 
<pubDate>2011-3-18</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0231.htm</link> 
<title>Effects of Expanded Human Adipose Tissue-Derived Mesenchymal Stem Cells on the Viability of Cryopreserved Fat Grafts in the Nude Mouse</title> 
<description><![CDATA[ <p>Adipose-derived mesenchymal stem cells (AdMSCs) augment the ability to contribute to microvascular remodeling <i>in vivo</i> and to modulate vascular stability in fresh fat grafts. Although cryopreserved adipose tissue is frequently used for soft tissue augmentation, the viability of the fat graft is poor. The effects of culture-expanded human adipose tissue-derived mesenchymal stem cells (hAdMSCs) on the survival and quality of the cryopreserved fat graft were determined. hAdMSCs from the same donor were mixed with fat tissues cryopreserved at -70&#176;C for 8 weeks and injected subcutaneously into 6-week-old BALB/c-nu nude mice. Graft volume and weight were measured, and histology was evaluated 4 and 15 weeks post-transplantation. The hAdMSC-treated group showed significantly enhanced graft volume and weight. The histological evaluation demonstrated significantly better fat cell integrity compared with the vehicle-treated control 4 weeks post-transplantation. No significant difference in graft weight, volume, or histological parameters was found among the groups 15 weeks post-transplantation. The hAdMSCs enhanced the survival and quality of transplanted cryopreserved fat tissues. Cultured and expanded hAdMSCs have reconstructive capacity in cryopreserved fat grafting by increasing the number of stem cells.</p> ]]></description>  
<dc:creator>Myung-Soon Ko, Ji-Youl Jung, Il-Seob Shin, Eun-Wha Choi, Jae-Hoon Kim, Sung Keun Kang, Jeong Chan Ra</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>231</prism:startingPage> 
<prism:endingPage>238</prism:endingPage> 
<pubDate>2011-3-14</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0222.htm</link> 
<title>Characterization of Human Erythrocytes as Potential Carrier for Pravastatin: An In Vitro Study</title> 
<description><![CDATA[ <p>Drug delivery systems including chemical, physical and biological agents that enhance the bioavailability, improve pharmacokinetics and reduce toxicities of the drugs. Carrier erythrocytes are one of the most promising biological drug delivery systems investigated in recent decades. The bioavailability of statin drugs is low due the effects of P-glycoprotein in the gastro-intestinal tract as well as the first-pass metabolism. Therefore in this work we study the effect of time, temperature as well as concentration on the loading of pravastatin in human erythrocytes to be using them as systemic sustained release delivery system for this drug. After the loading process is performed the carriers' erythrocytes were physically and cellulary characterized. Also, the <i>in vitro </i>release of pravastatin from carrier erythrocytes was studied over time interval. Our results revealed that, human erythrocytes have been successfully loaded with pravastatin using endocytosis method either at 25<sup>o</sup>C or at 37<sup>o</sup>C. The loaded amount at 10 mg/ml is 0.32mg/0.1 ml and 0.69 mg/0.1 ml. Entrapment efficiency is 34% and 94% at 25<sup>o</sup>C and 37<sup>o</sup>C respectively at drug concentration 4 mg/ml. Moreover the percent of cells recovery is 87-93%. Hematological parameters and osmotic fragility behavior of pravastatin loaded erythrocytes were similar that of native erythrocytes. Scanning electron microscopy demonstrated that the pravastatin loaded cells has no change in the morphology. Pravastatin releasing from carrier cell was 83% after 23 hours in phosphate buffer saline and decreased to 72% by treatment of carrier cells with glutaraldehyde. The releasing pattern of the drug from loaded erythrocytes obeyed first order kinetics. It concluded that pravastatin is successfully entrapped into erythrocytes with acceptable loading parameters and moderate morphological changes, this suggesting that erythrocytes can be used as prolonged release for pravastatin.</p> ]]></description>  
<dc:creator>Gamal El-din I. Harisa, Mohamed F. Ibrahim, Fars K. Alanazi</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>222</prism:startingPage> 
<prism:endingPage>230</prism:endingPage> 
<pubDate>2011-3-11</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0216.htm</link> 
<title>Effects of Flurbiprofen on CRP, TNF-&#945;, IL-6, and Postoperative Pain of Thoracotomy</title> 
<description><![CDATA[ <p><b>Objective</b>: The aims of this study were to evaluate serum levels of acute phase reactants, such as CRP and cytokines (TNF-&#945; and IL-6) in patients who have undergone thoracotomy and to investigate the effects of flurbiprofen on postoperative inflammatory response.</p><p><b>Methods</b>: Forty patients undergoing posterolateral thoracotomy were randomly divided into 2 groups of 20 each. Control group received tramadol (4 x 100 mg) intravenously for four days, and flurbiprofen group received both tramadol (4 x 100 mg) and flurbiprofen (2 x 100 mg). Blood samples were collected before surgery and at the 3th and 168th hours after surgical procedure to measure serum CRP, IL-6, and TNF-&#945;. Pain visual analog scales were recorded daily during the first four postoperative days. Spirometric measurement of forced expiratory volume in the first second (FEV 1) was done before and four days after the operation.</p><p><b>Results</b>: The serum CRP, IL-6, and TNF-&#945; levels in both groups increased significantly at 3th hour after thoracotomy. Serum TNF-&#945; levels did not differ significantly between the groups at postoperative 4th day. However, IL-6 and CRP were significantly lower in flurbiprofen group than in control group at the same day (p&#60;0.05). Visual analog scale was significantly lower in flurbiprofen group at 6th, 12th, 48th, 72th, and 96th hours postoperatively (p&#60;0.05). The patients receiving flurbiprofen had higher FEV 1 values when compared with control group at postoperative 4th day.</p><p><b>Conclusions</b>: Patients undergoing thoracotomy showed reduced postoperative pain, mean additional analgesic consumption, and serum IL-6 and CRP levels, when flurbiprofen was added to systemic analgesic therapy. Analgesia with anti-inflammatory drug may contribute to the attenuation of the postoperative inflammatory response and prevent postoperative pain in patients undergoing thoracotomy.</p> ]]></description>  
<dc:creator>Hidir Esme, Recep Kesli, Burhan Apiliogullari, Ferdane Melike Duran, Banu Yoldas</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>216</prism:startingPage> 
<prism:endingPage>221</prism:endingPage> 
<pubDate>2011-3-10</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0210.htm</link> 
<title>Risk Factors for Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer</title> 
<description><![CDATA[ <p><b>Objective:</b> Previously, we suggested that oxaliplatin (L-OHP)-related grade 3/4 hypersensitivity reactions occurred immediately after the initiation, but grade 1/2 reactions did not. This study was conducted to clarify the risk factors for L-OHP-related hypersensitivity reactions.</p><p><b>Methods:</b> Clinical data from 108 Japanese patients with colorectal cancer were analyzed, who were treated with L-OHP-containing regimens, FOLFOX4 and/or mFOLFOX6. The risk factors examined included demographic data, preexisting allergies, laboratory test data, treatment regimen, treatment line of therapy, pretreatment with steroids, total number of cycles and cumulative amount of L-OHP.</p><p><b>Results:</b> The incidence of grade 1/2 and grade 3/4 hypersensitivity reactions were found at 13.0% (14/108) and 9.3% (10/108), respectively. Female (P=0.037), preexisting allergies (P=0.004) and lower level of lactate dehydrogenase (P=0.003) were risk factors for grade 1/2 hypersensitivity reactions, and higher neutrophil count (P=0.043) and lower monocyte count (P=0.007) were for grade 3/4 reactions. Total number of cycles were larger in the patients with grade 3/4 reactions than those without reactions (P=0.049).</p><p><b>Conclusions:</b> Further extensive examination with a large number of patients is needed to establish a patient management strategy.</p> ]]></description>  
<dc:creator>Kyoko Seki, Kenzou Senzaki, Yasuo Tsuduki, Takeshi Ioroi, Michiko Fujii, Hiroko Yamauchi, Yukinari Shiraishi, Izumi Nakata, Kohshi Nishiguchi, Teruhisa Matsubayashi, Yoshihide Takakubo, Noboru Okamura, Motohiro Yamamori, Takao Tamura, Toshiyuki Sakaeda</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>210</prism:startingPage> 
<prism:endingPage>215</prism:endingPage> 
<pubDate>2011-3-10</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0203.htm</link> 
<title>Expression of Human Globular Adiponectin-Glucagon-Like Peptide-1 Analog Fusion Protein and Its Assay of Glucose-Lowering Effect In Vivo</title> 
<description><![CDATA[ <p>In this study, human globular adiponectin-glucagon-like peptide-1 analog (gAd-GLP-1-A) fusion protein was expressed and its glucose-lowering effect was measured in vivo. We constructed a prokaryotic expression vector PET28a-gAd-GLP-1-A and transformed the vector into <i>Escherichia coli</i> BL21 (DE3). A recombinant fusion protein of about 25KD was expressed from BL21 (DE3) cells after isopropylthio-&#946;-D-galactoside induction. This protein was N-terminal His-tagged gAd-GLP-1-A fusion protein. Most of the protein was expressed in inclusion body. The fusion protein in inclusion body was purified by using High-Affinity Nickel Iminodiacetic Acid Resin and refolded in urea gradient refolding buffer. The refolded protein was incubated with enterokinase to remove the N-terminal His-tag. The fusion protein without His-tag is gAd-GLP-1-A fusion protein, which exhibited significant glucose-lowering effect in diabetic mice.</p> ]]></description>  
<dc:creator>Tongfeng Zhao, Jing Lv, Jiangpei Zhao, Xiao Huang, Haijuan Xiao</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>203</prism:startingPage> 
<prism:endingPage>209</prism:endingPage> 
<pubDate>2011-3-4</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0198.htm</link> 
<title>Antimicrobial Susceptibilities of Brucella Isolates from Various Clinical Speciemens</title> 
<description><![CDATA[ <p><b>Purpose:</b> Brucellosis is a worldwide zoonotic disease and still constitutes a major public health problem. In the study we claimed to identify <i>Brucella</i> species from clinical samples of patients with active brucellosis from Van region of Eastern Anatolia and to determine in vitro antimicrobial susceptibilities of these strains to commonly used anti-Brucella agents and a possible new alternative tigecycline.</p><p><b>Materials and Methods:</b> A total of 56 <i>Brucella </i>isolates were enrolled the study and the identification of the isolates were based on conventional methods. In vitro activities of antimicrobials were evaluated by the E test method.</p><p><b>Results:</b> All isolates were identified as <i>B. melitensis</i>. MIC<sub>90</sub> values of doxycycline, streptomycin, rifampin, trimethoprim-sulfamethoxazole and tigecycline were 0.064 mg/L, 1 mg/L, 2 mg/L, 0.125 mg/L and 0.094 mg/L, respectively. Tigecycline had low MIC<sub>50</sub> and MIC<sub>90</sub> values against all <i>B. melitensis </i>strains; the highest MIC observed was 0.25 &#956;g/mL.</p><p><b>Conclusion: </b>Our data suggest that tigecycline can be a therapeutic alternative option for the treatment of brucellosis.</p> ]]></description>  
<dc:creator>Yasemin Bayram, Hanifi Korkoca, Cenk Aypak, Mehmet Parlak, Aytekin Cikman, Selcuk Kilic, Mustafa Berktas</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>198</prism:startingPage> 
<prism:endingPage>202</prism:endingPage> 
<pubDate>2011-3-3</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0192.htm</link> 
<title>Effect of Acute Administration of an Herbal Preparation on Blood Pressure and Heart Rate in Humans</title> 
<description><![CDATA[ <p>Confusion and controversy exist regarding the cardiovascular effects of dietary supplements containing caffeine and <i>Citrus aurantium</i> (bitter orange) extract. The primary protoalkaloidal ingredient in bitter orange extract is<i> p</i>-synephrine which has some structural similarities to ephedrine and nor-epinehrine, but exhibits markedly different pharmacokinetic and receptor binding properties. The goal of this study was to investigate the cardiovascular effects of a product containing caffeine, bitter orange extract (<i>p</i>-synephrine) and green tea extract in mildly overweight individuals. Fourteen female and nine male subjects (age 24.7 &#177;7.4 yrs, BMI: 26.6 &#177;3.8) volunteered in this randomized, placebo-controlled, crossover, double-blind designed study. On day one, subjects entered the laboratory following an overnight fast. Heart rate and blood pressure were recorded at 60 min. Expired air was analyzed for the next 10 min of the session. At each of three meals, subjects ingested one capsule that was either a non-caloric placebo or a dietary supplement that contained 13 mg p-synephrine and 176 mg caffeine. On the following day, the subjects returned and repeated the protocol for data collection beginning 60 min after consuming one capsule of the placebo or the dietary supplement. No effects of the dietary supplement on heart rate, systolic and diastolic blood pressure or mean arterial pressure were observed. No between or within group differences were observed when data were analyzed for gender and caffeine usage. A small but significant decrease in resting respiratory exchange ratio was observed for the low caffeine user group in response to the product containing caffeine and <i>p</i>-synephrine. The results of this study indicate that ingestion of a product containing bitter orange extract, caffeine and green tea extract does not lead to increased cardiovascular stress and that fat oxidation may increase in certain populations.</p> ]]></description>  
<dc:creator>John G. Seifert, Aaron Nelson, Julia Devonish, Edmund R. Burke, Sidney J. Stohs</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>192</prism:startingPage> 
<prism:endingPage>197</prism:endingPage> 
<pubDate>2011-3-2</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0180.htm</link> 
<title>A Comparative Effectiveness Study of Bone Density Changes in Women Over 40 Following Three Bone Health Plans Containing Variations of the Same Novel Plant-sourced Calcium</title> 
<description><![CDATA[ <p><b>Background</b>: The US Surgeon General's Report on Bone Health suggests America's bone-health is in jeopardy and issued a &#8220;call to action&#8221; to develop bone-health plans incorporating components of (1) improved nutrition, (2) increased health literacy, and (3) increased physical activity.</p><p><b>Objective</b>: To conduct a Comparative Effectiveness Research (CER) study comparing changes in bone mineral density in healthy women over-40 with above-average compliance when following one of three bone health Plans incorporating the SG's three components.</p><p><b>Methods</b>: Using an open-label sequential design, 414 females over 40 years of age were tested, 176 of whom agreed to participate and follow one of three different bone-health programs. One Plan contained a bone-health supplement with 1,000 IUs of vitamin D<sub>3 </sub>and 750 mg of a plant-sourced form of calcium for one year. The other two Plans contained the same plant form of calcium, but with differing amounts of vitamin D<sub>3</sub> and other added bone health ingredients along with components designed to increase physical activity and health literacy. Each group completed the same baseline and ending DXA bone density scans, 43-chemistry blood test panels, and 84-item Quality of Life Inventory (QOL). Changes for all subjects were annualized as percent change in BMD from baseline. Using self-reports of adherence, subjects were rank-ordered and dichotomized as &#8220;compliant&#8221; or &#8220;partially compliant&#8221; based on the median rating. Comparisons were also made between the treatment groups and two theoretical age-adjusted expected groups: a non-intervention group and a group derived from a review of previously published studies on non-plant sources of calcium.</p><p><b>Results</b>: There were no significant differences in baseline BMD between those who volunteered versus those who did not and between those who completed per protocol (PP) and those who were lost to attrition. Among subjects completing per protocol, there were no significant differences between the three groups on baseline measurements of BMD, weight, age, body fat and fat-free mass suggesting that the treatment groups were statistically similar at baseline. In all three treatment groups subjects with above average compliance had significantly greater increases in BMD as compared to the two expected-change reference groups. The group following the most nutritionally comprehensive Plan outperformed the other two groups. For all three groups, there were no statistically significant differences between baseline and ending blood chemistry tests or the QOL self-reports.</p><p><b>Conclusions</b>: The increases in BMD found in all three treatment groups in this CER stand in marked contrast to previous studies reporting that interventions with calcium and vitamin D<sub>3</sub> reduce age-related losses of BMD, but do not increase BMD. Increased compliance resulted in increased BMD levels. No adverse effects were found in the blood chemistry tests, self-reported quality of life and daily tracking reports. The Plans tested suggest a significant improvement over the traditional calcium and vitamin D<sub>3</sub> standard of care.</p> ]]></description>  
<dc:creator>Gilbert R. Kaats, Harry G. Preuss, Harry A. Croft, Samuel C. Keith, Patti L. Keith</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>3</prism:number> 
<prism:startingPage>180</prism:startingPage> 
<prism:endingPage>191</prism:endingPage> 
<pubDate>2011-3-2</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0168.htm</link> 
<title>Microarray Analysis of Differential Gene Expression Profile in Peripheral Blood Cells of Patients with Human Essential Hypertension</title> 
<description><![CDATA[ <p>The polygenic nature of essential hypertension and its dependence on environmental factors pose a challenge for biomedical research. We hypothesized that the analysis of gene expression profiles from peripheral blood cells would distinguish patients with hypertension from normotensives. In order to test this, total RNA from peripheral blood cells was isolated. RNA was reversed-transcribed and labeled and gene expression analyzed using significance Analysis Microarrays (Stanford University, CA, USA). Briefly, Significance Analysis Microarrays (SAM) thresholding identified 31 up-regulated and 18 down-regulated genes with fold changes of &#8805;2 or&#8804;0.5 and q-value &#8804;5 % in expression. Statistically significantly gene ontology (GO) function and biological process differentially expressed in essential hypertension were MHC class II receptor activity and immune response respectively. Biological pathway analysis identified several related pathways which are associated with immune/inflammatory responses. Quantitative Real- Time RT-PCR results were consistent with the microarray results. The levels of C - reactive protein were higher in hypertensive patients than normotensives and inflammation-related genes were increased as well. In conclusion, genes enriched for &#8220;immune/inflammatory responses&#8221; may be associated with essential hypertension. In addition, there is a correlation between systemic inflammation and hypertension. It is anticipated that these findings may provide accurate and efficient strategies for prevention, diagnosis and control of this disorder.</p> ]]></description>  
<dc:creator>Melvin T. Korkor, Fan Bo Meng, Shen Yang Xing, Mu Chun Zhang, Jin Rui Guo, Xiao Xue Zhu, Ping Yang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>168</prism:startingPage> 
<prism:endingPage>179</prism:endingPage> 
<pubDate>2011-2-27</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0161.htm</link> 
<title>Anticancer Activity of the PR Domain of Tumor Suppressor RIZ1</title> 
<description><![CDATA[ <p>Human tumor suppressor gene <i>RIZ</i> encodes two protein products, tumor suppressor RIZ1 and proto-oncoprotein RIZ2, which regulate cellular functions in a Yin-Yang fashion. The only structural difference between them is that RIZ2 lacks the N-terminal PR domain. In this study, we showed that RIZ1 mRNA expression level was elevated in stage IV of eight different types of cancer (stage III for prostate cancer), indicating that RIZ1 might play an important role in tumor metastasis, and the PR domain alone possessed anticancer activity.</p> ]]></description>  
<dc:creator>Wanpeng Sun, Ling Qiao, Qiang Liu, Lifeng Chen, Binbing Ling, Ramaswami Sammynaiken, Jian Yang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>161</prism:startingPage> 
<prism:endingPage>167</prism:endingPage> 
<pubDate>2011-2-21</pubDate>
<category>Short Research Communication</category>
</item>

<item>
<link>http://www.medsci.org/v08p0156.htm</link> 
<title>Efficacy of the Valsalva Maneuver on Needle Projection Pain and Hemodynamic Responses During Spinal Puncture</title> 
<description><![CDATA[ <p>This study evaluated the efficacy of the valsalva maneuver that can induce baroreceptor activation and nociception, on needle projection pain and hemodynamic responses associated with spinal puncture. Ninety adults, ASA physical status I and II undergoing elective surgeries were included. Patients were randomized into three equal groups. Group I (C): control; Group II (B): ball; pressed a rubber ball (attention-diverting method); Group III (V): valsalva; blew into sphygmomanometer tubing and hold the mercury column up to 30 mm Hg for a period of at least 20s. Spinal needle projection pain was graded using numeric rating scale (NRS): 1-10, where scales of 1-3 were rated as mild, 4-6 as moderate, and &#62; 6 as severe. Blood pressure and heart rate, five minutes before the procedure, during the spinal puncture and first and third minutes after that, were also recorded. Significant reduction in NRS was observed in the valsalva group compared with the control and the ball groups (p=0.001). There were statistical but no significant clinical differences in mean arterial blood pressure and heart rates between the study groups (P=0.008 and P=0.016 respectively). In conclusion valsalva maneuver can decrease the skin puncture pain associated with spinal needle projection while observing hemodynamic changes.</p> ]]></description>  
<dc:creator>Sussan Soltani Mohammadi, Amin Ghasemi Pajand, Gita Shoeibi</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>156</prism:startingPage> 
<prism:endingPage>160</prism:endingPage> 
<pubDate>2011-2-16</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0148.htm</link> 
<title>The Value of Serum Biomarkers (Bc1, Bc2, Bc3) in the Diagnosis of Early Breast Cancer</title> 
<description><![CDATA[ <p><b>Background:</b> Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF) is an approach to biomarker discovery that combines chromatography and mass spectrometry. We aimed to consider the efficacy of Bc1, Bc2, and Bc3 serum biomarkers on early detection of breast cancer (BC) in this study.</p><p><b>Study Design:</b> In this prospective study, 91 patients who were admitted to our hospital between January 2007 and July 2008 were included. Serum samples from 91 women were stored at -80 &#176;C until use. The cancer group included 27 cases of BC. The benign breast disease group included 24 women with benign breast diseases and control group 37 age-matched apparently healthy women. The data obtained for these three groups of patients was worked out for each serum biomarker (Bc1, Bc2, and Bc3) by using SELDI-TOF individually and compared with each other separately and evaluated statistically.</p><p><b>Results:</b> Bc2 possesses the highest individual diagnostic power. Bc2 was statistically significant in comparison between the malignant disease group, control group and benign disease group. Bc1 was statistically significant in the malignant disease group compared to control group as well as in the benign disease group compared to control group. Thus Bc1, rather than showing malignant progression, it shows tumoral progression or inflammatory process. Bc3 was found upregulated in all malignant cases; however, it was not statistically significant compared to the benign disease group or the control group.</p><p><b>Conclusions:</b> It has been shown that Bc2 profiles might be useful in clinical practice to improve BC diagnosis. However none of the proteomics reach reasonable AUC values for the discrimination of the BC. Additional confirmation in larger and similarly-designed prospective studies is needed to consider of the efficacy of Bc1 and Bc2 in early diagnosis of the BC.</p> ]]></description>  
<dc:creator>Kemal Atahan, Hakan K&#252;peli, Serhat G&#252;r, T&#252;rkan Yi&#287;itba&#351;&#305;, Yasemin Bask&#305;n, Seyran Yi&#287;it, Mehmet Deniz, Atilla &#199;&#246;kmez, Erc&#252;ment Tarcan</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>148</prism:startingPage> 
<prism:endingPage>155</prism:endingPage> 
<pubDate>2011-2-12</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0139.htm</link> 
<title>Relationship between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients with Rheumatoid Arthritis</title> 
<description><![CDATA[ <p><b>Objective/Aim: </b>A new group of autoantibodies in Rheumatoid Arthritis (RA), the anti-cyclic citrullinated peptide (anti-CCP) antibodies directed to citrulline-containing proteins, which are of value for the severity of RA. Up to date, the relationship between anti-CCP antibodies and oxidant, anti-oxidant activity in patients with RA has not been elucidated in the previous studies. In this study we aimed to investigate the effect of anti-CCP antibodies in the circulation on whole blood, serum and synovial fluid oxidant and anti-oxidant activity in patients with RA. <b>Materials and Methods:</b> RA patients with anti-CCP (+) (n=25) and anti-CCP (-) (n=24) were recruited into the study. All patients had a positive rheumatoid factor (RF). The patients who were under treatment with only non-steroidal antiinflammatory drugs (NSAID) at the study time included in the study. Catalase (CAT), Glutathione peroxidase (GSHPx), Myeloperoxidase (MPO) activities and the levels of Malondialdehyde (MDA) were measured in whole blood, serum and synovial fluid in both groups. <b>Results: </b>There were no significant differences in terms of the mean whole blood and serum antioxidative activity (CAT, GSHpx) and the mean blood and serum MDA and MPO values (oxidative activity), between the patients with anti-CCP(+) and those with anti-CCP(-). There was increased synovial oxidant activity (MDA and MPO levels) (p&#60;0.05) in anti-CCP(+) RA patients with or without ESR negativity when compared with anti-CCP(-) RA patients. There was positive correlation between anti-CCP antibody levels and synovial MDA and MPO levels (r=0.435, p&#60;0.05, r=0.563, p&#60;0.05 respectively) in anti-CCP (+) group.<b> Conclusions:</b> In conclusion, anti-CCP antibody positivity seems to be associated with increased synovial fluid oxidant activity (increased MDA and MPO levels) in patients with RA. These conclusions need to be validated in a larger controlled study population.</p> ]]></description>  
<dc:creator>Levent Ediz, Ozcan Hiz, Halil Ozkol, Elif Gulcu, Murat Toprak, Mehmet Fethi Ceylan</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>139</prism:startingPage> 
<prism:endingPage>147</prism:endingPage> 
<pubDate>2011-2-9</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0126.htm</link> 
<title>High Dose Astaxanthin Lowers Blood Pressure and Increases Insulin Sensitivity in Rats: Are These Effects Interdependent?</title> 
<description><![CDATA[ <p>The present investigation in Sprague-Dawley rats (SD) was designed to examine effects of astaxanthin (Asta) at different doses on elevated blood pressure (BP) and glucose-insulin perturbations produced by heavy sucrose ingestion. We also examined effects of Asta on BP during restraint stress. SD were divided into six groups each containing eight rats. All SD ate a basic diet of ground regular rat chow with sucrose added at 30% w/w. The Control group received only the basic diet containing added sucrose, while the other five groups each received the same diet with added test material: captopril, (30 mg/Kg), pioglitazone (15.0 mg/Kg), low Asta (25 mg/Kg), medium Asta (50 mg/kg) or high Asta (100 mg/Kg). Many tests were carried out to examine the mechanisms behind the effects of Asta on BP (serum ACE activity, losartan challenge, and LNAME challenge) and the glucose-insulin system (glucose tolerance, HOMA measurement, and insulin challenge). In SD, a relatively low dose of Asta decreased SBP, but produced no major changes in the glucose-insulin system simulating results from a previous study using Zucker Fatty Rats. Increasing the dose of Asta resulted in both a lowering of elevated systolic BP and enhanced insulin sensitivity determined by many different estimations. BP lowering was consistent with changes in the renin-angiotensin (RAS) and nitric oxide (NO) systems. At the examined doses of each, captopril lowered BP in SD without influencing glucose-insulin metabolism, whereas pioglitazone favorably affected glucose-insulin metabolism while showing essentially no effects on BP. Accordingly, Asta beneficially affects both sucrose-induced elevations of BP and insulin resistance at relatively high doses in SD. Also, Asta at higher doses lessens restraint stress, whereas, captopril and pioglitazone did not at the doses examined, even though they influenced the BP and glucose-insulin systems respectively.</p> ]]></description>  
<dc:creator>Harry G. Preuss, Bobby Echard, Eiji Yamashita, Nicholas V. Perricone</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>126</prism:startingPage> 
<prism:endingPage>138</prism:endingPage> 
<pubDate>2011-2-9</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0114.htm</link> 
<title>The Influence of Hyperbaric Oxygen Treatment on the Healing of Experimental Defects Filled with Different Bone Graft Substitutes</title> 
<description><![CDATA[ <p>To assess potential effects of hyperbaric oxygen (HBOT) on artificial bone grafts, &#946; - Tricalcium phosphate (&#946;-TCP) and calcium phosphate coated bovine bone (CPCBB) substitutes were applied to standard bone defects in rat tibiae. The control defects were left empty. Half of the animals received 60 minutes of 2.4 atmosphere absolute (ATA) of HBOT. Rats were sacrificed at one, two and four weeks. Bone healing was assessed histologically and histomorphometrically using light microscopy. The periosteum over the bone defects was examined ultrastructurally. Cardiac blood was collected to determine the serum osteocalcin levels. The HBOT increased new bone formation in the unfilled controls and &#946;-TCP groups and significantly decreased cartilage matrix and fibrous tissue formations in all groups. Active osteoblasts and highly organized collagen fibrils were prominent in the periosteum of &#946;-TCP and control groups. Serum osteocalcin levels also increased with HBOT. The healing of defects filled with CPCBB was similar to the controls and it did not respond to HBOT. These findings suggested that the HBOT had beneficial effects on the healing of unfilled bone defects and those filled with &#946;-TCP bone substitute but not with CPCBB, indicating a material-specific influence pattern of HBOT.</p> ]]></description>  
<dc:creator>Yigit Sirin, Vakur Olgac, Semra Dogru-Abbasoglu, Leyla Tapul, Samil Aktas, Sinan Soley</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>114</prism:startingPage> 
<prism:endingPage>125</prism:endingPage> 
<pubDate>2011-2-8</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0106.htm</link> 
<title>Segment-orientated analysis of two-dimensional strain and strain rate as assessed by velocity vector imaging in patients with acute myocardial infarction</title> 
<description><![CDATA[ <p><b>Aims</b>: Strain rate imaging techniques have been proposed for the detection of ischemic or viable myocardium in coronary artery disease, which is still a challenge in clinical cardiology. This retrospective comparative study analyzed regional left ventricular function and scaring with two-dimensional strain (2DS) in the first 4 to 10 days after acute anterior myocardial infarction (AMI).</p><p><b>Methods and results:</b> The study population consisted of 32 AMI patients with an LAD occlusion and successful reperfusion. The assessment of peak systolic 2DS and peak systolic strain rate (SR) was performed segment-oriented with the angle-independent speckle tracking algorithm Velocity Vector Imaging (VVI). The infarcted, adjacent and non-infarcted segments were revealed by late enhancement MRI (LE-MRI), which was used as reference for the comparison with 2DS. The infarcted segments showed a significant decrease of tissue velocities, 2DS and SR in comparison to the non-affected segments.</p><p><b>Conclusion</b>: 2DS and SR as assessed by VVI seem to be a suitable approach for echocardiographic quantification of global and regional myocardial function as well as a promising tool for multimodal risk stratification after anterior AMI.</p> ]]></description>  
<dc:creator>Thomas Butz, Corinna N. Lang, Marc van Bracht, Magnus W. Prull, Hakan Yeni, Petra Maagh, Gunnar Plehn, Axel Meissner, Hans-Joachim Trappe</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>106</prism:startingPage> 
<prism:endingPage>113</prism:endingPage> 
<pubDate>2011-2-1</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0097.htm</link> 
<title>Positioning Effects of KillerRed inside of Cells correlate with DNA Strand Breaks after Activation with Visible Light</title> 
<description><![CDATA[ <p>Fluorescent proteins (FPs) are established tools for new applications, not-restricted to the cell biological research. They could also be ideal in surgery enhancing the precision to differentiate between the target tissue and the surrounding healthy tissue. FPs like the KillerRed (KRED), used here, can be activated by excitation with visible day-light for emitting active electrons which produce reactive oxygen species (ROS) resulting in photokilling processes. It is a given that the extent of the KRED's cell toxicity depends on its subcellular localization. Evidences are documented that the nuclear lamina as well as especially the chromatin are critical targets for KRED-mediated ROS-based DNA damaging. Here we investigated the damaging effects of the KRED protein fused to the nuclear lamina and to the histone H2A DNA-binding protein. We detected a frequency of DNA strand breaks, dependent first on the illumination time, and second on the spatial distance between the localization at the chromatin and the site of ROS production. As a consequence we could identify defined DNA bands with 200, 400 and (600) bps as most prominent degradation products, presumably representing an internucleosomal DNA cleavage induced by KRED. These findings are not restricted to the detection of programmed cell death processes in the therapeutic field like PDT, but they can also contribute to a better understanding of the structure-function relations in the epigenomic world.</p> ]]></description>  
<dc:creator>Waldemar Waldeck, Gabriele Mueller, Manfred Wiessler, Katalin T&#243;th, Klaus Braun</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>97</prism:startingPage> 
<prism:endingPage>105</prism:endingPage> 
<pubDate>2011-1-21</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0088.htm</link> 
<title>Parvovirus B19 Nonstructural Protein-Induced Damage of Cellular DNA and Resultant Apoptosis</title> 
<description><![CDATA[ <p>Parvovirus B19 is a widespread virus with diverse clinical presentations. The viral nonstructural protein, NS1, binds to and cleaves the viral genome, and induces apoptosis when transfected into nonpermissive cells, such as hepatocytes. We hypothesized that the cytotoxicity of NS1 in such cells results from chromosomal DNA damage caused by the DNA-nicking and DNA-attaching activities of NS1. Upon testing this hypothesis, we found that NS1 covalently binds to cellular DNA and is modified by PARP, an enzyme involved in repairing single-stranded DNA nicks. We furthermore discovered that the DNA nick repair pathway initiated by poly(ADPribose)polymerase and the DNA repair pathways initiated by ATM/ATR are necessary for efficient apoptosis resulting from NS1 expression.</p> ]]></description>  
<dc:creator>Brian D. Poole, Violetta Kivovich, Leona Gilbert, Stanley J. Naides</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>2</prism:number> 
<prism:startingPage>88</prism:startingPage> 
<prism:endingPage>96</prism:endingPage> 
<pubDate>2011-1-15</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0084.htm</link> 
<title>Bronchial Anthracofibrosis Case with Endobronchial Tuberculosis</title> 
<description><![CDATA[ <p>We reported a case with bronchial anthracofibrosis and endobronchial tuberculosis. Our case demonstrated this possible correlation between anthracofibrosis and endobronchial tuberculosis. We showed this correlation visually and microbiologically.</p> ]]></description>  
<dc:creator>Taha T. Bekci, Emin Maden, Levent Emre</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>84</prism:startingPage> 
<prism:endingPage>87</prism:endingPage> 
<pubDate>2011-1-11</pubDate>
<category>Case Report</category>
</item>

<item>
<link>http://www.medsci.org/v08p0074.htm</link> 
<title>Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head</title> 
<description><![CDATA[ <p>In this study, we investigated the feasibility and safety of intravenous transplantation of allogeneic bone marrow mesenchymal stem cells (MSCs) for femoral head repair, and observed the migration and distribution of MSCs in hosts. MSCs were labeled with green fluorescent protein (GFP) in vitro and injected into nude mice via vena caudalis, and the distribution of MSCs was dynamically monitored at 0, 6, 24, 48, 72 and 96 h after transplantation. Two weeks after the establishment of a rabbit model of femoral head necrosis, GFP labeled MSCs were injected into these rabbits via ear vein, immunological rejection and graft versus host disease were observed and necrotic and normal femoral heads, bone marrows, lungs, and livers were harvested at 2, 4 and 6 w after transplantation. The sections of these tissues were observed under fluorescent microscope. More than 70 % MSCs were successfully labeled with GFP at 72 h after labeling. MSCs were uniformly distributed in multiple organs and tissues including brain, lungs, heart, kidneys, intestine and bilateral hip joints of nude mice. In rabbits, at 6 w after intravenous transplantation, GFP labeled MSCs were noted in the lungs, liver, bone marrow and normal and necrotic femoral heads of rabbits, and the number of MSCs in bone marrow was higher than that in the, femoral head, liver and lungs. Furthermore, the number of MSCs peaked at 6 w after transplantation. Moreover, no immunological rejection and graft versus host disease were found after transplantation in rabbits. Our results revealed intravenously implanted MSCs could migrate into the femoral head of hosts, and especially migrate directionally and survive in the necrotic femoral heads. Thus, it is feasible and safe to treat femoral head necrosis by intravenous transplantation of allogeneic MSCs.</p> ]]></description>  
<dc:creator>Zhang-hua Li, Wen Liao, Xi-long Cui, Qiang Zhao, Ming Liu, You-hao Chen, Tian-shu Liu, Nong-le Liu, Fang Wang, Yang Yi, Ning-sheng Shao</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>74</prism:startingPage> 
<prism:endingPage>83</prism:endingPage> 
<pubDate>2011-1-9</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0068.htm</link> 
<title>Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turkey</title> 
<description><![CDATA[ <p><b>Background:</b> Our purpose was to investigate the clinical outcomes of Zotarolimus- and Paclitaxel-eluting stents in Turkish patients with coronary artery disease (CAD). In general, the outcome of drug-eluting stent (DES) placement has a proven efficacy in randomized trials. However, the difference in efficacy between the Zotarolimus and Paclitaxel-eluting stents in unselected Turkish patients is controversial. Therefore, we investigated the clinical outcomes of these two drug-eluting stents in the real-world.</p><p><b>Methods:</b> We created a registry and prospectively analyzed data on a consecutive series of all patients who presented to our institution with symptomatic coronary artery disease between February 2005 and March 2007 and who were treated with the zotarolimus- or the paclitaxel-eluting stent. The follow-up period was approximately two years. The primary end-point was major cardiac events, and the secondary end-point was definite stent thrombosis. Informed consent was obtained from all subjects, and the study protocol was approved by the local ethical committee.</p><p><b>Results:</b> In total, 217 patients were treated with either the zotarolimus-eluting stent (n = 116) or the paclitaxel-eluting stent (n = 101). The lesions in the 2 arms of the study were treated similarly by conventional technique. At 24-month follow-up the paclitaxel-eluting stent group showed significantly higher non-Q wave myocardial infarction (2.6% vs 5.9%, p: 0.02), Q wave myocardial infarction (1.7% vs 5.9%, p: 0.049), coronary artery binding graft surgery (2.6% vs 6.9%, p: 0.002), and late stent thrombosis (1.7% vs 3.9%, p: 0.046).</p><p><b>Conclusions:</b> Zotarolimus-eluting stents demonstrated better clinical outcomes than Paclitaxel-eluting stents in a daily routine practice of coronary intervention in an unselected Turkish population.</p> ]]></description>  
<dc:creator>Davran &#199;i&#231;ek, Hasan Pekdemir, Cevahir Haberal, Nihat Kalay, S&#252;leyman Binici, Hakan Altay, Haldun M&#252;derriso&#287;lu</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>68</prism:startingPage> 
<prism:endingPage>73</prism:endingPage> 
<pubDate>2011-1-8</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0056.htm</link> 
<title>Helicobacter pylori induces mitochondrial DNA mutation and reactive oxygen species level in AGS cells</title> 
<description><![CDATA[ <p>To investigate the role of ROS in the helicobacter pylori (Hp) induced mtDNA mutations, AGS cells were treated by extracts of Hp11638 or Hp11638M. The ROS levels, cytochrome C reductions, and intracellular ATP levels were measured. The coding region and the D-Loop region were amplified and sequenced. Results showed the ROS levels, cytochrome C reduction and mtDNA mutations were markedly increased and cell viability decreased after treatment with both Hp extracts, and 616 mutations were detected in D-Loop region and 3 heteroplasmic point mutations in the Cytb gene. No mutations were found in the coding region. The mutation rates of mtDNA D-Loop region were positively correlated with the ROS levels and negatively to the ATP levels.</p> ]]></description>  
<dc:creator>Xue-Wen Huang, Rui-Hua Luo, Qi Zhao, Zhong-Ze Shen, Li-Li Huang, Xian-Yuan An, Lan-Jing Zhao, Jie Wang, Yu-Zheng Huang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>56</prism:startingPage> 
<prism:endingPage>67</prism:endingPage> 
<pubDate>2011-1-8</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0048.htm</link> 
<title>Ozone Therapy and Hyperbaric Oxygen Treatment in Lung Injury in Septic Rats</title> 
<description><![CDATA[ <p>Various therapeutic protocols were used for the management of sepsis including hyperbaric oxygen (HBO) therapy. It has been shown that ozone therapy (OT) reduced inflammation in several entities and exhibits some similarity with HBO in regard to mechanisms of action. We designed a study to evaluate the efficacy of OT in an experimental rat model of sepsis to compare with HBO. Male Wistar rats were divided into sham, sepsis+cefepime, sepsis+cefepime+HBO, and sepsis+cefepime+OT groups. Sepsis was induced by an intraperitoneal injection of <i>Escherichia coli</i>; HBO was administered twice daily; OT was set as intraperitoneal injections once a day. The treatments were continued for 5 days after the induction of sepsis. At the end of experiment, the lung tissues and blood samples were harvested for biochemical and histological analysis. Myeloperoxidase activities and oxidative stress parameters, and serum proinflammatory cytokine levels, IL-1&#946; and TNF-&#945;, were found to be ameliorated by the adjuvant use of HBO and OT in the lung tissue when compared with the antibiotherapy only group. Histologic evaluation of the lung tissue samples confirmed the biochemical outcome. Our data presented that both HBO and OT reduced inflammation and injury in the septic rats' lungs; a greater benefit was obtained for OT. The current study demonstrated that the administration of OT as well as HBO as adjuvant therapy may support antibiotherapy in protecting the lung against septic injury. HBO and OT reduced tissue oxidative stress, regulated the systemic inflammatory response, and abated cellular infiltration to the lung demonstrated by findings of MPO activity and histopathologic examination. These findings indicated that OT tended to be more effective than HBO, in particular regarding serum IL-1&#946;, lung GSH-Px and histologic outcome.</p> ]]></description>  
<dc:creator>Levent Yamanel, Umit Kaldirim, Yesim Oztas, Omer Coskun, Yavuz Poyrazoglu, Murat Durusu, Tuncer Cayci, Ahmet Ozturk, Seref Demirbas, Mehmet Yasar, Orhan Cinar, Salim Kemal Tuncer, Yusuf Emrah Eyi, Bulent Uysal, Turgut Topal, Sukru Oter, Ahmet Korkmaz</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>48</prism:startingPage> 
<prism:endingPage>55</prism:endingPage> 
<pubDate>2011-1-3</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0039.htm</link> 
<title>MALDI-TOF MS Combined With Magnetic Beads for Detecting Serum Protein Biomarkers and Establishment of Boosting Decision Tree Model for Diagnosis of Colorectal Cancer</title> 
<description><![CDATA[ <p>The aim of present study is to study the serum protein fingerprint of patients with colorectal cancer (CRC) and to screen protein molecules that are closely related to colorectal cancer during the onset and progression of the disease with Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Serum samples from 144 patients with CRC and 120 healthy volunteers were adopted in present study. Weak cation exchange (WCX) magnetic beads and PBSII-C protein chips reader (Ciphergen Biosystems Ins.) were used. The protein fingerprint expression of all the Serum samples and the resulted profiles between cancer and normal groups were analyzed with Biomarker Wizard system. Several proteomic peaks were detected and four potential biomarkers with different expression profiles were identified with their relative molecular weights of 2870.7Da, 3084Da, 9180.5Da, and 13748.8Da, respectively. Among the four proteins, two proteins with m/z 2870.7 and 3084 were down-regulated, and the other two with m/z 9180.5 and 13748.8 were up-regulated in serum samples from CRC patients. The present diagnostic model could distinguish CRC from healthy controls with the sensitivity of 92.85% and the specificity of 91.25%. Blind test data indicated a sensitivity of 86.95% and a specificity of 85%. The result suggested that MALDI technology could be used to screen critical proteins with differential expression in the serum of CRC patients. These differentially regulated proteins were considered as potential biomarkers for the patients with CRC in the serum and of the potential value for further investigation.</p> ]]></description>  
<dc:creator>Chibo Liu, Chunqin Pan, Jianmin Shen, Haibao Wang, Liang Yong</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>39</prism:startingPage> 
<prism:endingPage>47</prism:endingPage> 
<pubDate>2011-1-3</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0030.htm</link> 
<title>Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia</title> 
<description><![CDATA[ <p>Iron deficiency anemia (IDA) is a frequent disorder. Also, it may be a sign of underlying serious diseases. Iron deficiency points to an occult or frank bleeding lesion when occurred in men or postmenopausal women. In this study, we aimed to evaluate the diagnostic yield of endoscopy in patients with IDA and to define predictive factors of gastrointestinal (GI) lesions causing IDA. Ninety-one patients (77 women, 14 men; mean age: 43 years) who were decided to have esophago-duodenoscopy and/or colonoscopy for iron deficiency anemia were interviewed and responded to a questionnaire that included clinical and biochemical variables. The endoscopic findings were recorded as GI lesions causing IDA or not causing IDA. Endoscopy revealed a source of IDA in 18.6 % of cases. The risk factors for finding GI lesions causing IDA were as follows: male gender (p= 0.004), advanced age (&#62; 50 years) (p= 0.010), weight loss (over 20% of total body weight lost in last 6 month) (p= 0.020), chronic diarrhea (p= 0.006), change of bowel habits (p= 0.043), epigastric tenderness (p= 0.037), raised carcinoembryonic antigen (CEA) level (normal range: 0-7 ng/mL) (p= 0.039), &#60; 10 gr/dl hemoglobin (Hb) level (p=0.054). None of these risk factors had been present in 21 (23%) women younger than 51 years. In this group, no patient had any GI lesion likely to cause IDA (negative predictive value= 100%). In multivariate analysis, advanced age (p=0.017), male gender (p&#60; 0.01) and weight lost (p=0.012) found that associated with GI lesions in all patients. It may be an appropriate clinical approach to consider these risk factors when deciding for gastrointestinal endoscopic evaluation in iron deficiency anemia.</p> ]]></description>  
<dc:creator>Songul Serefhanoglu, Yahya Buyukasik, Hakan Emmungil, Nilgun Sayinalp, Ibrahim Celalettin Haznedaroglu, Hakan Goker, Salih Aksu, Osman Ilhami Ozcebe</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>30</prism:startingPage> 
<prism:endingPage>38</prism:endingPage> 
<pubDate>2010-12-28</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0016.htm</link> 
<title>A Novel Population of Mesenchymal Progenitors with Hematopoietic Potential Originated from CD14- Peripheral Blood Mononuclear Cells</title> 
<description><![CDATA[ <p>Hemopoietic system derived progenitor cells with mesenchymal features have been identified including CD14<sup>+</sup> monocyte-derived progenitors. However, it is unclear whether there are mesenchyme derived progenitors with hematopoietic potential. Herein, we identified a novel CD14<sup>-</sup> cell-derived population with both mesenchymal and hematopoietic features in rat peripheral blood, and this cell population is different from the CD14<sup>+</sup> monocyte-derived progenitors but designated peripheral blood multipotential mesenchymal progenitors (PBMMPs). Phenotype analysis demonstrated expression of mesenchymal markers in PBMMPs including BMPRs, Endoglin/CD105, Fibronectin (Fn), Vimentin (Vim), Collagen (Col) I/II/III along with hematopoietic marker CD34. CD14<sup>+</sup> cell-derived population shared the same characteristics with CFs. In mixed culture of CD14<sup>+</sup> and CD14<sup>-</sup> cells, PBMMPs were a predominant component and expressed CD29<sup>high</sup>, CD73<sup>high</sup>, CD34<sup>high</sup>, CD45<sup>low</sup> and CD90. Except for the value of mixed T lymphocytes and CD14<sup>+</sup> cell-derived population, hematopoietic characters of cultured PBMMPs were indicated by CD14<sup>-</sup>/CD34<sup>+</sup>/CD45<sup>-</sup>/CD90<sup>+</sup>. The mesenchymal origin was further confirmed by comparing PBMMPs with bone marrow stromal cells. Finally, we transplanted PBMMPs into a skin wound model, and results showed the specific potential of PBMMPs in not only extracellular matrix secretion but epidermal regeneration. This study provides evidence that peripheral blood contains common hematopoietic-mesenchymal progenitors from both hematopoietic and mesenchymal lineages, and CD34<sup>+</sup> mesenchymal progenitors are a possible alternative source of epidermal cells in wound healing.</p> ]]></description>  
<dc:creator>Gang Hu, Peng Liu, Jie Feng, Yan Jin</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>16</prism:startingPage> 
<prism:endingPage>29</prism:endingPage> 
<pubDate>2010-12-27</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0009.htm</link> 
<title>Experimental ablation of the pancreas with high intensity focused ultrasound (HIFU) in a porcine model</title> 
<description><![CDATA[ <p>The aim of this study was to determine the feasibility and safety of high intensity focused ultrasound's (HIFU) in pancreatic diseases. Twelve pigs were divided into three groups. The pancreases of pigs in Group A were ablated directly with HIFU, but those in Group B and C ablated by extracorporeal HIFU. The pigs in Group C were sacrificed at day 7 after HIFU. Serological parameters were determined pre-operation and post-operation. The entire pancreas was removed for histological examination. Each animal tolerate the HIFU ablation well. The complete necrosis was observed in targeted regions. The margins of the necrotic regions were clearly delineated from the surrounding normal tissues. Infiltration of inflammatory cells and phorocytosis on the boundary were found in group C. Blood and urine amylase levels were relatively steady after HIFU. No acute pancreatitis or severe complications occurred. In conclusion, HIFU ablation on the pancreas was safe and effective in experimental pigs.</p> ]]></description>  
<dc:creator>Biao Xie, Yu-Yuan Li, Lin Jia, Yu-Qiang Nie, Hong Du, Shu-Man Jiang</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>9</prism:startingPage> 
<prism:endingPage>15</prism:endingPage> 
<pubDate>2010-12-17</pubDate>
<category>Research Paper</category>
</item>

<item>
<link>http://www.medsci.org/v08p0001.htm</link> 
<title>6-Month Results of Transdiscal Biacuplasty on Patients with Discogenic Low Back Pain: Preliminary Findings</title> 
<description><![CDATA[ <p><b>Study Design: </b>Prospective observational study.</p><p><b>Objective:</b> Our aim is to investigate the efficacy and safety of TransDiscal Biacuplasty.</p><p><b>Summary of Background Data:</b> Chronic discogenic pain is one of the leading causes of low back pain; however, the condition is not helped by most non-invasive methods. The results of major surgical operations for these patients are unsatisfactory. Recently, attention has shifted to disk heating methods for treatment. TransDiscal Biacuplasty is one of the minimally invasive treatment methods. The method was developed as an alternative to spinal surgical practices and Intradiscal Electrothermal Therapy for treatment of patients with chronic discogenic pain.</p><p><b>Methods: </b>The candidates for this study were patients with chronic discogenic pain that did not respond to conservative treatment. The main criteria for inclusion were: the existence of axial low back pain present for 6 months; disc degeneration or internal disc disruption at a minimum of one level, and maximum of two levels, in MR imaging; and positive discography. Physical function was assessed using the Oswestry Disability Index when measuring the pain with VAS. Patient satisfaction was evaluated using a 4-grade scale. Follow-ups were made 1, 3, and 6 months after treatment.</p><p><b>Results:</b> 15 patients were treated at one or two levels. The mean patient age was 43.1&#177;9.2 years. We found the mean symptom duration to be 40.5&#177;45.7 months. At the sixth month, 57.1% of patients reported a 50% or more reduction in pain, while 78.6% of patients reported a reduction of at least two points in their VAS values. In the final check, 78.6% of patients reported a 10-point improvement in their Oswestry Disability scores compared to the initial values. No complications were observed in any of the patients.</p><p><b>Conclusions: </b>TransDiscal Biacuplasty is an effective and safe method.</p> ]]></description>  
<dc:creator>Haktan Karaman, Adnan T&#252;fek, G&#246;n&#252;l &#214;lmez Kavak, Sedat Kaya, Zeynep Baysal Yildirim, Ersin Uysal, Feyzi &#199;elik</dc:creator>
<dc:source>International Journal of Medical Sciences</dc:source>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
<prism:volume>8</prism:volume> 
<prism:number>1</prism:number> 
<prism:startingPage>1</prism:startingPage> 
<prism:endingPage>8</prism:endingPage> 
<pubDate>2010-12-14</pubDate>
<category>Research Paper</category>
</item>

<atom:link href="http://www.medsci.org/rss/v8.xml" rel="self" type="application/rss+xml" />
</channel>
</rss>
